REACH Certificate of Compliance 205 SVHC

Updated 28 January 2020

For the following equipment:

Product Name:
Power Supplies, adaptors, transformers, all Part #'s including “(R)” or marked “RoHS”.

(Manufacturer Name)(Manufacturer Address)
1. GlobTek, Inc. USA186 Veterans Drive, Northvale, NJ USA 07647

GlobTek Inc. fully supports and hereby certifies complete conformance to the requirements of REACH's 205 SVHC (Substances of Very High Concern in accordance with Article 59(10) of the REACH Regulation), the European Community Regulation standard about chemicals and their safe use (EC 1907/2006) which is a new law entered into force on 1 June 2007 which will be phased in until 2018.

With regard to the requirement of Article 67 of Reach : A substance on its own, in preparation or in an article, for which Annex XVII, contains a restriction shall not be manufactured, placed on the market or used unless it complies with the conditions of that restriction. We declare that none of the substances in the Conditions of restriction is present in GlobTek's products (and also package)

As REACH regulation is updated frequently, for the major changes afterwards, such as the addition of SVHC substances into Annex XIV, the addition of restricted substances in Annex XVII, GlobTek Inc will evaluate the further revise in time and update this declaration to reflect those changes

GlobTek, Inc. is committed to providing safe products consistent with the improvement and protection of human health and the environment through the better and earlier identification of the intrinsic properties of chemical substances.

GlobTek Inc. is conforming and will continue to conform to the requirements of REACH as new amendments are released. Specifically, the below listed chemical substances are not present in our products for quantities totaling over one ton per producer a year, and are not present above a concentration of 0.1% by weight.

QA Department: Hans Moritz
Signature: signature
Date: 28 January 2020
Substance name Description EC No. CAS No. Reason for inclusion Date of inclusion Decision IUCLID dataset Support document Response to comments Remarks
Perfluorobutane sulfonic acid (PFBS) and its salts
- - Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)#Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) 16/01/2020 https://echa.europa.eu/documents/10162/079c04a0-2464-4168-f132-a22ffb04d910 https://echa.europa.eu/documents/10162/53791353-6577-a9e8-5600-c5ef51864652 https://echa.europa.eu/documents/10162/891ab33d-d263-cc4b-0f2d-d84cfb7f424a https://echa.europa.eu/documents/10162/c31deaac-42ea-e070-dc46-4ad7cbd911c5 The combined intrinsic properties justifying the inclusion as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following: very high persistence, high mobility in water and soil, high potential for long-range transport, and difficulty of remediation and water purification as well as moderate bioaccumulation in humans. The observed probable serious effects for human health and the environment are thyroid hormonal disturbances and reproductive toxicity seen in rodents, and effects on liver, kidney and haematological system in rats, hormonal disturbances and effects on reproduction in marine medaka fish and effects on expression of hormone receptors in tadpoles. Together, these elements lead to a very high potential for irreversible effects.
Diisohexyl phthalate
276-090-2 71850-09-4 Toxic for reproduction (Article 57c) 16/01/2020 https://echa.europa.eu/documents/10162/802ed481-8bf1-0096-61a4-0bbd2f9b573c https://echa.europa.eu/documents/10162/c9adbb8d-3989-2380-cb54-f34940de0002 https://echa.europa.eu/documents/10162/cc11a6e1-0b26-8a5d-189d-417eb06a60d4 https://echa.europa.eu/documents/10162/557d7a67-fcad-3a12-6798-b63f1766e209
2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one
400-600-6 71868-10-5 Toxic for reproduction (Article 57c) 16/01/2020 https://echa.europa.eu/documents/10162/7d1e26b8-37af-4f0b-0d0f-5edb0b6e5a7f https://echa.europa.eu/documents/10162/e31382a6-3e8a-a858-da3d-614c10f6c75d https://echa.europa.eu/documents/10162/e4917be1-32fd-dbd6-e305-90f269d446dd https://echa.europa.eu/documents/10162/eaf8f0fd-8ee6-e16a-099e-d37ec9fb9680
2-benzyl-2-dimethylamino-4'-morpholinobutyrophenone
404-360-3 119313-12-1 Toxic for reproduction (Article 57c) 16/01/2020 https://echa.europa.eu/documents/10162/ba42270a-93fe-7cde-6d41-7f7af4e00e66 https://echa.europa.eu/documents/10162/dfd0d651-604f-f33f-0831-3672c1cbb580 https://echa.europa.eu/documents/10162/6d5c6d89-bd66-3c04-4a31-f580476b88b4 https://echa.europa.eu/documents/10162/c101661c-1d54-aa4d-2bde-4ad2357323de
Tris(4-nonylphenyl, branched and linear) phosphite (TNPP) with ≥ 0.1% w/w of 4-nonylphenol, branched and linear (4-NP)
- - Endocrine disrupting properties (Article 57(f) - environment) 16/07/2019 https://echa.europa.eu/documents/10162/a661cbe6-c805-b9c7-1287-53dee5cd1df5 https://echa.europa.eu/documents/10162/8da7df6b-e62f-47f7-d9d1-154f8db267f8 https://echa.europa.eu/documents/10162/ceb2fc2c-78f2-627f-29ae-b37c0e91bc69 https://echa.europa.eu/documents/10162/19d55d1d-1cc8-6431-265b-032a569c2fb8
tris(4-nonylphenyl, branched) phosphite
701-028-2 - Endocrine disrupting properties (Article 57(f) - environment) 16/07/2019 https://echa.europa.eu/documents/10162/a661cbe6-c805-b9c7-1287-53dee5cd1df5 https://echa.europa.eu/documents/10162/8da7df6b-e62f-47f7-d9d1-154f8db267f8 https://echa.europa.eu/documents/10162/ceb2fc2c-78f2-627f-29ae-b37c0e91bc69 https://echa.europa.eu/documents/10162/19d55d1d-1cc8-6431-265b-032a569c2fb8
Tris(nonylphenyl) phosphite
247-759-6 26523-78-4 Endocrine disrupting properties (Article 57(f) - environment) 16/07/2019 https://echa.europa.eu/documents/10162/a661cbe6-c805-b9c7-1287-53dee5cd1df5 https://echa.europa.eu/documents/10162/8da7df6b-e62f-47f7-d9d1-154f8db267f8 https://echa.europa.eu/documents/10162/ceb2fc2c-78f2-627f-29ae-b37c0e91bc69 https://echa.europa.eu/documents/10162/19d55d1d-1cc8-6431-265b-032a569c2fb8
Phenol, 4-nonyl-, phosphite (3:1)
608-492-4 3050-88-2 Endocrine disrupting properties (Article 57(f) - environment) 16/07/2019 https://echa.europa.eu/documents/10162/a661cbe6-c805-b9c7-1287-53dee5cd1df5 https://echa.europa.eu/documents/10162/8da7df6b-e62f-47f7-d9d1-154f8db267f8 https://echa.europa.eu/documents/10162/ceb2fc2c-78f2-627f-29ae-b37c0e91bc69 https://echa.europa.eu/documents/10162/19d55d1d-1cc8-6431-265b-032a569c2fb8
4-tert-butylphenol
202-679-0 98-54-4 Endocrine disrupting properties (Article 57(f) - environment) 16/07/2019 https://echa.europa.eu/documents/10162/ca2542ab-a35b-1c00-5490-708d59332c38#https://echa.europa.eu/documents/10162/99a7e1c6-2aa4-0c35-acc3-35ec26bb1ee8 https://echa.europa.eu/documents/10162/fedde563-03f7-51f0-85fd-1fceb0eaa18f https://echa.europa.eu/documents/10162/41de4b52-51f3-84e9-3f9c-fa6f868139ad https://echa.europa.eu/documents/10162/2c66d98c-d2a2-e146-265e-b8a1615e5c17
2-methoxyethyl acetate
203-772-9 110-49-6 Toxic for reproduction (Article 57c) 16/07/2019 https://echa.europa.eu/documents/10162/b7bc601c-ad77-4e90-0cdf-2701a59478fb https://echa.europa.eu/documents/10162/eea50979-c40b-f00f-b767-891e93941ee1 https://echa.europa.eu/documents/10162/874297f1-6d65-b808-a62e-5d23cc5f1e5c https://echa.europa.eu/documents/10162/85320f87-c256-b1b5-8cd6-42d997128032
2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionic acid, its salts and its acyl halides covering any of their individual isomers and combinations thereof - - Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)#Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) 16/07/2019 https://echa.europa.eu/documents/10162/fc76aefc-fc86-a5fc-b5c4-e358467ca832 https://echa.europa.eu/documents/10162/c07bc76c-4d62-7799-d0d4-17e43508aeb0 https://echa.europa.eu/documents/10162/53fa6a5b-e95f-3128-ea9d-fa27f43b18bc https://echa.europa.eu/documents/10162/9d2b14b6-853a-15d6-e0b6-38ccf3da781d The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.
Potassium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionate
266-578-3 67118-55-2 Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)#Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) 16/07/2019 https://echa.europa.eu/documents/10162/fc76aefc-fc86-a5fc-b5c4-e358467ca832 https://echa.europa.eu/documents/10162/c07bc76c-4d62-7799-d0d4-17e43508aeb0 https://echa.europa.eu/documents/10162/53fa6a5b-e95f-3128-ea9d-fa27f43b18bc https://echa.europa.eu/documents/10162/9d2b14b6-853a-15d6-e0b6-38ccf3da781d The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.
2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionic acid
236-236-8 13252-13-6 Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)#Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) 16/07/2019 https://echa.europa.eu/documents/10162/fc76aefc-fc86-a5fc-b5c4-e358467ca832 https://echa.europa.eu/documents/10162/c07bc76c-4d62-7799-d0d4-17e43508aeb0 https://echa.europa.eu/documents/10162/53fa6a5b-e95f-3128-ea9d-fa27f43b18bc https://echa.europa.eu/documents/10162/9d2b14b6-853a-15d6-e0b6-38ccf3da781d The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.
2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionyl fluoride
218-173-8 2062-98-8 Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)#Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) 16/07/2019 https://echa.europa.eu/documents/10162/fc76aefc-fc86-a5fc-b5c4-e358467ca832 https://echa.europa.eu/documents/10162/c07bc76c-4d62-7799-d0d4-17e43508aeb0 https://echa.europa.eu/documents/10162/53fa6a5b-e95f-3128-ea9d-fa27f43b18bc https://echa.europa.eu/documents/10162/9d2b14b6-853a-15d6-e0b6-38ccf3da781d The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.
Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoate
700-242-3 62037-80-3 Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health)#Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) 16/07/2019 https://echa.europa.eu/documents/10162/fc76aefc-fc86-a5fc-b5c4-e358467ca832 https://echa.europa.eu/documents/10162/c07bc76c-4d62-7799-d0d4-17e43508aeb0 https://echa.europa.eu/documents/10162/53fa6a5b-e95f-3128-ea9d-fa27f43b18bc https://echa.europa.eu/documents/10162/9d2b14b6-853a-15d6-e0b6-38ccf3da781d The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.The combined intrinsic properties justifying the inclusion for the Member State Committee as a substance for which there is scientific evidence of probable serious effects to human health and the environment which give rise to an equivalent level of concern are the following:
Persistence, mobility, potential for long-range transport, observed adverse effects (at least the following probable effects for human health: effects on the liver, the kidney, and the haematological and immune systems and effects on development; at least the following probable effects for the environment: population relevant effects on birds and mammals); as well as low adsorption potential and high water solubility rendering the substance fully bioavailable for uptake via (drinking) water. Together, these elements lead to a very high potential for irreversible effects.
Pyrene
204-927-3 129-00-0 PBT (Article 57d)#vPvB (Article 57e) 15/01/2019 https://echa.europa.eu/documents/10162/d6b1b306-6f05-9765-204a-689334527ef9 https://echa.europa.eu/documents/10162/bf9b02a4-6e4b-b1bf-2c58-6d61f5998817 https://echa.europa.eu/documents/10162/47121daf-04a7-6d4a-b0b6-595794d3e66c https://echa.europa.eu/documents/10162/ecfa3b19-c8e7-0016-7aab-a110a02d34a1
Phenanthrene
201-581-5 85-01-8 vPvB (Article 57e) 15/01/2019 https://echa.europa.eu/documents/10162/91535066-71da-d9b4-71cc-8d4003b7f983 https://echa.europa.eu/documents/10162/efc23200-6f59-12c6-4b18-533a80aa7b4f https://echa.europa.eu/documents/10162/c62a1c4a-ceec-3a00-52a4-0a298f7d8bb3 https://echa.europa.eu/documents/10162/e438fc9e-02b6-214d-bf7d-d3d8e36f5162
Fluoranthene
205-912-4 206-44-0 PBT (Article 57d)#vPvB (Article 57e) 15/01/2019 https://echa.europa.eu/documents/10162/21272691-d1a0-3334-fde9-a0782d9354a2 https://echa.europa.eu/documents/10162/375e39c4-c59b-bfbd-d156-a1bf2a959108 https://echa.europa.eu/documents/10162/0d1ee6d4-1a47-0737-35c7-3503f0fca417 https://echa.europa.eu/documents/10162/7e5022d4-fbaf-7170-8488-f8fd2c508632
Benzo[k]fluoranthene
205-916-6 207-08-9 Carcinogenic (Article 57a)#PBT (Article 57d)#vPvB (Article 57e) 15/01/2019 https://echa.europa.eu/documents/10162/afa7d75c-b83f-fef0-ae10-41e70a1e57f7 https://echa.europa.eu/documents/10162/ae8cba56-9884-9e35-34c7-0369a4703600 https://echa.europa.eu/documents/10162/06cc1281-efd9-9845-0215-e6b0c94c94db https://echa.europa.eu/documents/10162/aa74498e-1354-db8b-4ae4-e90fe8ad0744
2,2-bis(4'-hydroxyphenyl)-4-methylpentane
401-720-1 6807-17-6 Toxic for reproduction (Article 57c) 15/01/2019 https://echa.europa.eu/documents/10162/562afdb1-00aa-32ab-1022-721917185b12 https://echa.europa.eu/documents/10162/8ec5e70d-db99-d21c-c54b-9de01c41f435 https://echa.europa.eu/documents/10162/76cf3fb1-07eb-ff40-f41c-251f8c657b33 https://echa.europa.eu/documents/10162/c1077165-193e-eee1-a145-2bd925925912
1,7,7-trimethyl-3-(phenylmethylene)bicyclo[2.2.1]heptan-2-one 3-benzylidene camphor; 3-BC 239-139-9 15087-24-8 Endocrine disrupting properties (Article 57(f) - environment) 15/01/2019 https://echa.europa.eu/documents/10162/db2f223c-20a1-5318-d6b1-7a147d7f08c3#https://echa.europa.eu/documents/10162/56d708da-69e5-a7d1-e970-780352b8ed6a https://echa.europa.eu/documents/10162/22f73d01-dfc1-15d5-a8fe-a29b460fa108 https://echa.europa.eu/documents/10162/84e7e600-0f73-6a4a-b246-19482576aa20#https://echa.europa.eu/documents/10162/2e1c96ea-2918-90d2-9c23-e07effac4ec9#https://echa.europa.eu/documents/10162/0c80cbbd-998f-b415-f9be-9e3ced41f333 https://echa.europa.eu/documents/10162/cd9266ea-a15f-4a46-9ae4-773178241506
Terphenyl, hydrogenated
262-967-7 61788-32-7 vPvB (Article 57e) 27/06/2018 https://echa.europa.eu/documents/10162/fc78f7e5-8f8a-de84-1141-499c5e021d31 https://echa.europa.eu/documents/10162/b30abea4-5ba0-e195-f595-a617687ad1c1 https://echa.europa.eu/documents/10162/fb7a9167-7d65-dd4c-2aa2-b8182d4a8e37 https://echa.europa.eu/documents/10162/5cfb341a-f539-5736-1eb7-08996c0866ef
Octamethylcyclotetrasiloxane D4 209-136-7 556-67-2 PBT (Article 57d)#vPvB (Article 57e) 27/06/2018 https://echa.europa.eu/documents/10162/2be7bcbf-f797-c28c-2c67-939664155c7c https://echa.europa.eu/documents/10162/1c5dc0f3-cd5c-7b71-044a-9167e3b03d99 https://echa.europa.eu/documents/10162/115f70a9-a387-1525-d49f-b715e84996e4 https://echa.europa.eu/documents/10162/47ac46b8-b4ee-dcff-4c55-d21b0b83772d
Lead
231-100-4 7439-92-1 Toxic for reproduction (Article 57c) 27/06/2018 https://echa.europa.eu/documents/10162/61ac8d81-6ea2-6ad0-ffef-95037c9182ce https://echa.europa.eu/documents/10162/79eec48e-c0b6-0d58-5218-ddb32ce0d22d https://echa.europa.eu/documents/10162/07a87920-1b8f-b0d9-b6a7-1c0b1c16c8c4 https://echa.europa.eu/documents/10162/f612a924-8c2b-94d5-2577-6808472f9f80
Ethylenediamine EDA 203-468-6 107-15-3 Respiratory sensitising properties (Article 57(f) - human health) 27/06/2018 https://echa.europa.eu/documents/10162/2ed8a7b4-8e9f-2e3e-407d-819dbdaa1623 https://echa.europa.eu/documents/10162/0fa2b79d-e520-b857-6572-61c49095b5a3 https://echa.europa.eu/documents/10162/f0a61fa4-64d1-2d19-35ed-d98134aec10d https://echa.europa.eu/documents/10162/70e34c23-adfe-cef0-b71f-69f70b0009dd
Dodecamethylcyclohexasiloxane D6 208-762-8 540-97-6 PBT (Article 57d)#vPvB (Article 57e) 27/06/2018 https://echa.europa.eu/documents/10162/b11de9bc-6e60-01f9-cdeb-20fa3b7e864e https://echa.europa.eu/documents/10162/9061869f-7e55-aaac-9ea5-761b9050a952 https://echa.europa.eu/documents/10162/a9682f4b-fc3e-cd99-3db9-b0f9f383c3c5 https://echa.europa.eu/documents/10162/50402243-546c-5d76-3961-f7836b9427c8 Dodecamethylcyclohexasiloxane (D6) meets the criteria of Article 57 (d) of Regulation (EC) 1907/2006 (REACH) as a substance which is persistent, bioaccumulative and toxic when it contains ≥ 0.1 % w/w octamethylcyclotetrasiloxane (D4) (EC No. 209-136-7). In addition to its intrinsic properties, it also meets the criteria of Article 57 (e) of Regulation (EC) 1907/2006 (REACH) as a substance which is very persistent and very bioaccumulative (vPvB) when it contains ≥ 0.1 % w/w decamethylcyclopentasiloxane (D5) (EC No. 208-764-9) or ≥ 0.1% w/w octamethylcyclotetrasiloxane (D4) (EC No. 209-136-7).
Disodium octaborate
234-541-0 12008-41-2 Toxic for reproduction (Article 57c) 27/06/2018 https://echa.europa.eu/documents/10162/74a5fdff-6a00-d3b4-4056-a5b24ee9ba6e https://echa.europa.eu/documents/10162/62353089-57f4-c7c7-64f9-291364883323 https://echa.europa.eu/documents/10162/24e48bb3-3a68-1dfa-ef39-6e9f4ef92720 https://echa.europa.eu/documents/10162/0e851607-1e21-7fa1-5bec-ad942fa3263f
Dicyclohexyl phthalate DCHP 201-545-9 84-61-7 Toxic for reproduction (Article 57c)#Endocrine disrupting properties (Article 57(f) - human health) 27/06/2018 https://echa.europa.eu/documents/10162/8c434af5-cfbe-c87e-aa51-65893e385d1f#https://echa.europa.eu/documents/10162/2fe151f3-d425-cff3-fe31-d13c11afcc7a https://echa.europa.eu/documents/10162/1be86650-c2d6-326e-1991-735cbf66ecbf https://echa.europa.eu/documents/10162/919d3291-e835-609a-0800-03f64cda86b5#https://echa.europa.eu/documents/10162/14f99ef1-0f31-f9e7-7880-8404fda062fc#https://echa.europa.eu/documents/10162/b2995010-92b6-183f-2a3c-e5b823b537c9 https://echa.europa.eu/documents/10162/588b62dc-c945-db3a-3440-489f40d5b158
Decamethylcyclopentasiloxane D5 208-764-9 541-02-6 PBT (Article 57d)#vPvB (Article 57e) 27/06/2018 https://echa.europa.eu/documents/10162/1b8ab766-b3ff-840f-a0bd-f1ade391745d https://echa.europa.eu/documents/10162/32855182-9c49-d41f-150a-b6a6aa012fff https://echa.europa.eu/documents/10162/ddd97c9a-fe79-6f50-ff1a-c1d4bf305aab https://echa.europa.eu/documents/10162/6cd63239-fdf6-bb3b-1bfb-fdfd39a23fad Decamethylcyclopentasiloxane (D5) meets the criteria of Article 57 (d) of Regulation (EC) 1907/2006 (REACH) as a substance which is persistent, bioaccumulative and toxic when it contains ≥ 0.1 % w/w octamethylcyclotetrasiloxane (D4) (EC No: 209-136-7).
Benzo[ghi]perylene
205-883-8 191-24-2 PBT (Article 57d)#vPvB (Article 57e) 27/06/2018 https://echa.europa.eu/documents/10162/ef81b8a3-7ec8-1380-d2ff-db1ceae26073 https://echa.europa.eu/documents/10162/16752063-ed16-d532-0418-8613beeceab0 https://echa.europa.eu/documents/10162/b45e78cd-5d70-0dd9-e895-e9fa89ab43d0 https://echa.europa.eu/documents/10162/7b2c6d46-a79a-993d-f460-dc36161a3733
Benzene-1,2,4-tricarboxylic acid 1,2 anhydride trimellitic anhydride; TMA 209-008-0 552-30-7 Respiratory sensitising properties (Article 57(f) - human health) 27/06/2018 https://echa.europa.eu/documents/10162/996c1b49-d6f7-5899-c94a-43a04d98ef94#https://echa.europa.eu/documents/10162/a6547852-e697-84ec-512c-5ba264ecf09e https://echa.europa.eu/documents/10162/358de08d-e71f-b578-e833-71fec1df75d2 https://echa.europa.eu/documents/10162/c2b11ef6-5ca8-ba78-da4b-38baa59ac416#https://echa.europa.eu/documents/10162/e3f5cdaa-1633-1c3e-a50f-9fae7da39104#https://echa.europa.eu/documents/10162/2dc71f1b-fc2d-9e8c-40f0-0d3dcb5085eb https://echa.europa.eu/documents/10162/ad25cca6-7296-a41a-431f-0cc9ecd734d5
Reaction products of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and 4-heptylphenol, branched and linear (RP-HP) with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl) - - Endocrine disrupting properties (Article 57(f) - environment) 15/01/2018 https://echa.europa.eu/documents/10162/339e0894-361d-ab6c-615f-7e201376d128 https://echa.europa.eu/documents/10162/c8ea7b6a-06bc-eeaf-ae4d-3d980a6078bc https://echa.europa.eu/documents/10162/2064f792-8443-873c-27de-eae18f593b59#https://echa.europa.eu/documents/10162/b33d78f4-946c-1d4d-e923-1ade7869c464 https://echa.europa.eu/documents/10162/896de311-33b2-0ea3-8750-71fcf5d3572e
Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.
939-460-0 - Endocrine disrupting properties (Article 57(f) - environment) 15/01/2018 https://echa.europa.eu/documents/10162/339e0894-361d-ab6c-615f-7e201376d128 https://echa.europa.eu/documents/10162/c8ea7b6a-06bc-eeaf-ae4d-3d980a6078bc https://echa.europa.eu/documents/10162/2064f792-8443-873c-27de-eae18f593b59#https://echa.europa.eu/documents/10162/b33d78f4-946c-1d4d-e923-1ade7869c464 https://echa.europa.eu/documents/10162/896de311-33b2-0ea3-8750-71fcf5d3572e
Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine
300-298-5 93925-00-9 Endocrine disrupting properties (Article 57(f) - environment) 15/01/2018 https://echa.europa.eu/documents/10162/339e0894-361d-ab6c-615f-7e201376d128 https://echa.europa.eu/documents/10162/c8ea7b6a-06bc-eeaf-ae4d-3d980a6078bc https://echa.europa.eu/documents/10162/2064f792-8443-873c-27de-eae18f593b59#https://echa.europa.eu/documents/10162/b33d78f4-946c-1d4d-e923-1ade7869c464 https://echa.europa.eu/documents/10162/896de311-33b2-0ea3-8750-71fcf5d3572e
Chrysene
205-923-4 218-01-9 Carcinogenic (Article 57a)#PBT (Article 57d)#vPvB (Article 57e) 15/01/2018 https://echa.europa.eu/documents/10162/a7438bc1-a7fd-caef-d74a-ca33fc0f3610 https://echa.europa.eu/documents/10162/2b898da9-812d-8a07-e059-e81d2c2883cb https://echa.europa.eu/documents/10162/92791ee1-40a6-f4dd-a2fe-927f6f1cb478 https://echa.europa.eu/documents/10162/86c65434-fcf1-b935-4559-eb9e17cf996d
Cadmium nitrate
233-710-6 10325-94-7 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#Specific target organ toxicity after repeated exposure (Article 57(f) - human health) 15/01/2018 https://echa.europa.eu/documents/10162/d1e3a2d5-13a6-c5da-62cf-2d581d94b87d https://echa.europa.eu/documents/10162/8b38c499-dad0-ee30-11ab-198b55b2e69d https://echa.europa.eu/documents/10162/ac791555-9e63-3208-e176-cd0fdb4fbdf0 https://echa.europa.eu/documents/10162/f0ec2ec9-bbf8-384a-4f35-7bd1e410edde
Cadmium hydroxide
244-168-5 21041-95-2 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#Specific target organ toxicity after repeated exposure (Article 57(f) - human health) 15/01/2018 https://echa.europa.eu/documents/10162/deb481e6-b2f3-9792-7d2b-260a1f383dc1 https://echa.europa.eu/documents/10162/d6ad39ad-bbf7-562c-2042-a823ed29cc1e https://echa.europa.eu/documents/10162/38688481-353e-bac2-e83e-68f4c772aac7 https://echa.europa.eu/documents/10162/b2cc442c-e223-2cc1-481d-c3ca402da15c
Cadmium carbonate
208-168-9 513-78-0 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#Specific target organ toxicity after repeated exposure (Article 57(f) - human health) 15/01/2018 https://echa.europa.eu/documents/10162/53cefde3-40e9-8d3d-b52d-87a9d828871d https://echa.europa.eu/documents/10162/31f9a47b-191c-526e-0446-f10162fd312c https://echa.europa.eu/documents/10162/acc7ace6-0118-6d74-4446-38f5bbe0b6b6 https://echa.europa.eu/documents/10162/d3ca6657-9e6d-68f9-48c9-87737360e199
Benz[a]anthracene
200-280-6 56-55-3 Carcinogenic (Article 57a)#PBT (Article 57d)#vPvB (Article 57e) 15/01/2018 https://echa.europa.eu/documents/10162/6adbea83-2790-92a4-06cd-ce39c4bf3211 https://echa.europa.eu/documents/10162/7d8ac604-d716-4a97-8682-d3d5e5c4158f https://echa.europa.eu/documents/10162/75ad552f-1e59-2599-e379-55ecec998d3f https://echa.europa.eu/documents/10162/691e9c3a-6cc7-c90f-f4a2-e3e8dbe5282c
1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”™) covering any of its individual anti- and syn-isomers or any combination thereof - - vPvB (Article 57e) 15/01/2018 https://echa.europa.eu/documents/10162/23f967f0-d76c-c59c-6af3-c865006599b8 https://echa.europa.eu/documents/10162/78fb98fd-a8e7-31a3-f910-f2bad587d8a6 https://echa.europa.eu/documents/10162/9aa77dde-f0fc-4422-2c00-55b620e57552#https://echa.europa.eu/documents/10162/97b3c3bf-f38a-f3e2-6b53-45654bcc02dc https://echa.europa.eu/documents/10162/abca40a2-428f-603d-59f7-140218822afd
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
236-948-9 13560-89-9 vPvB (Article 57e) 15/01/2018 https://echa.europa.eu/documents/10162/23f967f0-d76c-c59c-6af3-c865006599b8 https://echa.europa.eu/documents/10162/78fb98fd-a8e7-31a3-f910-f2bad587d8a6 https://echa.europa.eu/documents/10162/9aa77dde-f0fc-4422-2c00-55b620e57552#https://echa.europa.eu/documents/10162/97b3c3bf-f38a-f3e2-6b53-45654bcc02dc https://echa.europa.eu/documents/10162/abca40a2-428f-603d-59f7-140218822afd
rel-(1R,4S,4aS,6aS,7S,10R,10aR,12aR)-1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro-1,4:7,10-dimethanodibenzo[a,e]cyclooctene
- - vPvB (Article 57e) 15/01/2018 https://echa.europa.eu/documents/10162/23f967f0-d76c-c59c-6af3-c865006599b8 https://echa.europa.eu/documents/10162/78fb98fd-a8e7-31a3-f910-f2bad587d8a6 https://echa.europa.eu/documents/10162/9aa77dde-f0fc-4422-2c00-55b620e57552#https://echa.europa.eu/documents/10162/97b3c3bf-f38a-f3e2-6b53-45654bcc02dc https://echa.europa.eu/documents/10162/abca40a2-428f-603d-59f7-140218822afd
rel-(1R,4S,4aS,6aR,7R,10S,10aS,12aR)-1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro-1,4:7,10-dimethanodibenzo[a,e]cyclooctene
- - vPvB (Article 57e) 15/01/2018 https://echa.europa.eu/documents/10162/23f967f0-d76c-c59c-6af3-c865006599b8 https://echa.europa.eu/documents/10162/78fb98fd-a8e7-31a3-f910-f2bad587d8a6 https://echa.europa.eu/documents/10162/9aa77dde-f0fc-4422-2c00-55b620e57552#https://echa.europa.eu/documents/10162/97b3c3bf-f38a-f3e2-6b53-45654bcc02dc https://echa.europa.eu/documents/10162/abca40a2-428f-603d-59f7-140218822afd
Perfluorohexane-1-sulphonic acid and its salts PFHxS - - vPvB (Article 57e) 07/07/2017 https://echa.europa.eu/documents/10162/20a23653-34b1-bb48-4887-7ea77bedc637 https://echa.europa.eu/documents/10162/a118329d-6a4f-f820-bbc0-94c640c0a9fa https://echa.europa.eu/documents/10162/149c1af7-6375-9ad5-a141-ec53d76b4707#https://echa.europa.eu/documents/10162/1f48372e-97dd-db9f-4335-8cec7ae55eee https://echa.europa.eu/documents/10162/d8329daf-93ea-4358-a70a-80b2960ad1a2
Potassium perfluorohexane-1-sulphonate
223-393-2 3871-99-6 vPvB (Article 57e) 07/07/2017 https://echa.europa.eu/documents/10162/20a23653-34b1-bb48-4887-7ea77bedc637 https://echa.europa.eu/documents/10162/a118329d-6a4f-f820-bbc0-94c640c0a9fa https://echa.europa.eu/documents/10162/149c1af7-6375-9ad5-a141-ec53d76b4707#https://echa.europa.eu/documents/10162/1f48372e-97dd-db9f-4335-8cec7ae55eee https://echa.europa.eu/documents/10162/d8329daf-93ea-4358-a70a-80b2960ad1a2
Perfluorohexane-1-sulphonic acid
206-587-1 355-46-4 vPvB (Article 57e) 07/07/2017 https://echa.europa.eu/documents/10162/20a23653-34b1-bb48-4887-7ea77bedc637 https://echa.europa.eu/documents/10162/a118329d-6a4f-f820-bbc0-94c640c0a9fa https://echa.europa.eu/documents/10162/149c1af7-6375-9ad5-a141-ec53d76b4707#https://echa.europa.eu/documents/10162/1f48372e-97dd-db9f-4335-8cec7ae55eee https://echa.europa.eu/documents/10162/d8329daf-93ea-4358-a70a-80b2960ad1a2
Tridecafluorohexanesulphonic acid, compound with 2,2'-iminodiethanol (1:1)
274-462-9 70225-16-0 vPvB (Article 57e) 07/07/2017 https://echa.europa.eu/documents/10162/20a23653-34b1-bb48-4887-7ea77bedc637 https://echa.europa.eu/documents/10162/a118329d-6a4f-f820-bbc0-94c640c0a9fa https://echa.europa.eu/documents/10162/149c1af7-6375-9ad5-a141-ec53d76b4707#https://echa.europa.eu/documents/10162/1f48372e-97dd-db9f-4335-8cec7ae55eee https://echa.europa.eu/documents/10162/d8329daf-93ea-4358-a70a-80b2960ad1a2
Ammonium perfluorohexane-1-sulphonate
269-511-6 68259-08-5 vPvB (Article 57e) 07/07/2017 https://echa.europa.eu/documents/10162/20a23653-34b1-bb48-4887-7ea77bedc637 https://echa.europa.eu/documents/10162/a118329d-6a4f-f820-bbc0-94c640c0a9fa https://echa.europa.eu/documents/10162/149c1af7-6375-9ad5-a141-ec53d76b4707#https://echa.europa.eu/documents/10162/1f48372e-97dd-db9f-4335-8cec7ae55eee https://echa.europa.eu/documents/10162/d8329daf-93ea-4358-a70a-80b2960ad1a2
p-(1,1-dimethylpropyl)phenol
201-280-9 80-46-6 Endocrine disrupting properties (Article 57(f) - environment) 12/01/2017 https://echa.europa.eu/documents/10162/c11b5b68-67f4-8044-53a6-26759a106c80 https://echa.europa.eu/documents/10162/c6fa630c-af6f-0df1-8f5d-ec0b890e58a3 https://echa.europa.eu/documents/10162/3cbffe6e-fc78-0884-e5cd-a519eccf6a02 https://echa.europa.eu/documents/10162/3802446e-2467-58c2-33bf-002d4f780032
Nonadecafluorodecanoic acid (PFDA) and its sodium and ammonium salts
- - Toxic for reproduction (Article 57c)#PBT (Article 57d) 12/01/2017 https://echa.europa.eu/documents/10162/df3daa02-0c97-2c3a-2c7b-90c267642086 https://echa.europa.eu/documents/10162/a1000164-695a-311d-3eb0-71c09e92dc84 https://echa.europa.eu/documents/10162/d580f392-aadd-459c-5bfa-7a2e4dd86032 https://echa.europa.eu/documents/10162/4b9da160-19c8-3bff-f8c8-080d98d7dade
Nonadecafluorodecanoic acid
206-400-3 335-76-2 Toxic for reproduction (Article 57c)#PBT (Article 57d) 12/01/2017 https://echa.europa.eu/documents/10162/df3daa02-0c97-2c3a-2c7b-90c267642086 https://echa.europa.eu/documents/10162/a1000164-695a-311d-3eb0-71c09e92dc84 https://echa.europa.eu/documents/10162/d580f392-aadd-459c-5bfa-7a2e4dd86032 https://echa.europa.eu/documents/10162/4b9da160-19c8-3bff-f8c8-080d98d7dade
Ammonium nonadecafluorodecanoate
221-470-5 3108-42-7 Toxic for reproduction (Article 57c)#PBT (Article 57d) 12/01/2017 https://echa.europa.eu/documents/10162/df3daa02-0c97-2c3a-2c7b-90c267642086 https://echa.europa.eu/documents/10162/a1000164-695a-311d-3eb0-71c09e92dc84 https://echa.europa.eu/documents/10162/d580f392-aadd-459c-5bfa-7a2e4dd86032 https://echa.europa.eu/documents/10162/4b9da160-19c8-3bff-f8c8-080d98d7dade
Decanoic acid, nonadecafluoro-, sodium salt
- 3830-45-3 Toxic for reproduction (Article 57c)#PBT (Article 57d) 12/01/2017 https://echa.europa.eu/documents/10162/df3daa02-0c97-2c3a-2c7b-90c267642086 https://echa.europa.eu/documents/10162/a1000164-695a-311d-3eb0-71c09e92dc84 https://echa.europa.eu/documents/10162/d580f392-aadd-459c-5bfa-7a2e4dd86032 https://echa.europa.eu/documents/10162/4b9da160-19c8-3bff-f8c8-080d98d7dade
4-heptylphenol, branched and linear substances with a linear and/or branched alkyl chain with a carbon number of 7 covalently bound predominantly in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof - - Endocrine disrupting properties (Article 57(f) - environment) 12/01/2017 https://echa.europa.eu/documents/10162/0f8c5cf3-ccb7-3df6-c351-1c2df00cbc91 https://echa.europa.eu/documents/10162/32f515fd-4785-d96a-5394-ace770b72b97 https://echa.europa.eu/documents/10162/f3dba6ab-8dd8-2457-4213-2f390b0539f1#https://echa.europa.eu/documents/10162/9ec084eb-b304-e40b-acd4-23761f9bb6cd https://echa.europa.eu/documents/10162/104c486b-3d42-2442-3038-439fbc6e0fde
Phenol, heptyl derivs.
276-743-1 72624-02-3 Endocrine disrupting properties (Article 57(f) - environment) 12/01/2017 https://echa.europa.eu/documents/10162/0f8c5cf3-ccb7-3df6-c351-1c2df00cbc91 https://echa.europa.eu/documents/10162/32f515fd-4785-d96a-5394-ace770b72b97 https://echa.europa.eu/documents/10162/f3dba6ab-8dd8-2457-4213-2f390b0539f1#https://echa.europa.eu/documents/10162/9ec084eb-b304-e40b-acd4-23761f9bb6cd https://echa.europa.eu/documents/10162/104c486b-3d42-2442-3038-439fbc6e0fde
4-heptylphenol
217-862-0 1987-50-4 Endocrine disrupting properties (Article 57(f) - environment) 12/01/2017 https://echa.europa.eu/documents/10162/0f8c5cf3-ccb7-3df6-c351-1c2df00cbc91 https://echa.europa.eu/documents/10162/32f515fd-4785-d96a-5394-ace770b72b97 https://echa.europa.eu/documents/10162/f3dba6ab-8dd8-2457-4213-2f390b0539f1#https://echa.europa.eu/documents/10162/9ec084eb-b304-e40b-acd4-23761f9bb6cd https://echa.europa.eu/documents/10162/104c486b-3d42-2442-3038-439fbc6e0fde
4,4'-isopropylidenediphenol Bisphenol A; BPA 201-245-8 80-05-7 Toxic for reproduction (Article 57c)#Endocrine disrupting properties (Article 57(f) - environment)#Endocrine disrupting properties (Article 57(f) - human health) 12/01/2017 https://echa.europa.eu/documents/10162/36834f25-582c-0855-37fb-bd20b409382c#https://echa.europa.eu/documents/10162/eeed2c09-2263-25ad-49cd-a0926736c877#https://echa.europa.eu/documents/10162/ede153a4-db00-daf6-120f-6b6ccce0c539 https://echa.europa.eu/documents/10162/a6dc6937-ccec-1024-8282-8304a76549fa https://echa.europa.eu/documents/10162/b10d6a00-8e47-9b14-4f61-c779a8dc8450#https://echa.europa.eu/documents/10162/908badc9-e65d-3bae-933a-3512a9262e59#https://echa.europa.eu/documents/10162/769b2777-19cd-9fff-33c4-54fe6d8290d5 https://echa.europa.eu/documents/10162/2cf952cc-a366-fe92-d87c-306f71dfc19b#https://echa.europa.eu/documents/10162/ffc0a157-d90e-05f9-aa7b-d300d81bb6e7#https://echa.europa.eu/documents/10162/38030450-aa82-74aa-f5cb-c7b4e2829e65
Benzo[def]chrysene (Benzo[a]pyrene)
200-028-5 50-32-8 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#Toxic for reproduction (Article 57c)#PBT (Article 57d)#vPvB (Article 57e) 20/06/2016 https://echa.europa.eu/documents/10162/4b054c5b-8511-4a30-8ef8-35ab143b4fd0 https://echa.europa.eu/documents/10162/75ad6d26-78d9-4903-b06a-cf69953713dc https://echa.europa.eu/documents/10162/985e117f-38e2-4d45-9d0c-94413dd0462e https://echa.europa.eu/documents/10162/2f947c2c-3bce-4613-ad40-27996e8a06fa
Perfluorononan-1-oic-acid and its sodium and ammonium salts
- - Toxic for reproduction (Article 57c)#PBT (Article 57d) 17/12/2015 https://echa.europa.eu/documents/10162/725df6cb-070c-48c9-89a5-500ee2dabe16 https://echa.europa.eu/documents/10162/2aa67f6e-621e-4337-84aa-076f0de11f4e https://echa.europa.eu/documents/10162/48ae5fe3-9436-4a10-a533-ed642b92ce47 https://echa.europa.eu/documents/10162/20e45dd9-b52f-4a35-aaaf-46e644ba5362
Perfluorononan-1-oic-acid
206-801-3 375-95-1 Toxic for reproduction (Article 57c)#PBT (Article 57d) 17/12/2015 https://echa.europa.eu/documents/10162/725df6cb-070c-48c9-89a5-500ee2dabe16 https://echa.europa.eu/documents/10162/2aa67f6e-621e-4337-84aa-076f0de11f4e https://echa.europa.eu/documents/10162/48ae5fe3-9436-4a10-a533-ed642b92ce47 https://echa.europa.eu/documents/10162/20e45dd9-b52f-4a35-aaaf-46e644ba5362
Sodium salts of perfluorononan-1-oic-acid
- -, 21049-39-8 Toxic for reproduction (Article 57c)#PBT (Article 57d) 17/12/2015 https://echa.europa.eu/documents/10162/725df6cb-070c-48c9-89a5-500ee2dabe16 https://echa.europa.eu/documents/10162/2aa67f6e-621e-4337-84aa-076f0de11f4e https://echa.europa.eu/documents/10162/48ae5fe3-9436-4a10-a533-ed642b92ce47 https://echa.europa.eu/documents/10162/20e45dd9-b52f-4a35-aaaf-46e644ba5362
Ammonium salts of perfluorononan-1-oic-acid
- -, 4149-60-4 Toxic for reproduction (Article 57c)#PBT (Article 57d) 17/12/2015 https://echa.europa.eu/documents/10162/725df6cb-070c-48c9-89a5-500ee2dabe16 https://echa.europa.eu/documents/10162/2aa67f6e-621e-4337-84aa-076f0de11f4e https://echa.europa.eu/documents/10162/48ae5fe3-9436-4a10-a533-ed642b92ce47 https://echa.europa.eu/documents/10162/20e45dd9-b52f-4a35-aaaf-46e644ba5362
Nitrobenzene
202-716-0 98-95-3 Toxic for reproduction (Article 57c) 17/12/2015 https://echa.europa.eu/documents/10162/bcde2926-a00e-4389-8e48-67122bceba67 https://echa.europa.eu/documents/10162/d51c9722-aed2-47a0-8356-831db2066b0a https://echa.europa.eu/documents/10162/d71ba080-df7e-42e6-a76f-4eec3880ebe5 https://echa.europa.eu/documents/10162/25b4427f-1c53-4497-8ca2-29d24a55f4b5
2-(2H-benzotriazol-2-yl)-4-(tert-butyl)-6-(sec-butyl)phenol (UV-350)
253-037-1 36437-37-3 vPvB (Article 57e) 17/12/2015 https://echa.europa.eu/documents/10162/aca017f7-ce9f-4bce-a991-7c9e911a3ddd https://echa.europa.eu/documents/10162/2721734c-c482-493b-82e8-3b4d131a6507 https://echa.europa.eu/documents/10162/13121440-8260-4e04-bc10-5dcad34c7ac0 https://echa.europa.eu/documents/10162/83d0d2e1-bfbf-4209-9305-1145ecab65b7
2,4-di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phenol (UV-327)
223-383-8 3864-99-1 vPvB (Article 57e) 17/12/2015 https://echa.europa.eu/documents/10162/86a55090-a222-4389-83d6-4859f9efb875 https://echa.europa.eu/documents/10162/b9c11f35-3120-4aa0-abec-d80c9aeb3786 https://echa.europa.eu/documents/10162/5d71b975-bba0-482d-9a5e-a102c7a0fc0d https://echa.europa.eu/documents/10162/97707461-6a49-4b79-ad36-83333004bc1b
1,3-propanesultone
214-317-9 1120-71-4 Carcinogenic (Article 57a) 17/12/2015 https://echa.europa.eu/documents/10162/e685b7a5-9825-4719-a746-ea358385f903 https://echa.europa.eu/documents/10162/ab2bd960-50e9-44b4-a02d-4a3c9a622bdc https://echa.europa.eu/documents/10162/08f7169e-1697-4323-b13a-b037046eff96 https://echa.europa.eu/documents/10162/5441ed97-c6bf-4157-b34b-5d2043ea9bce
5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [1], 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [2] covering any of the individual stereoisomers of [1] and [2] or any combination thereof - - vPvB (Article 57e) 15/06/2015 https://echa.europa.eu/documents/10162/f7c78fc1-bc3e-4913-9a8f-1f57e03326e4 https://echa.europa.eu/documents/10162/c87c2930-58af-20dd-8394-afcd0d96ee3f https://echa.europa.eu/documents/10162/a4fac134-09e6-43c1-a65f-dfaee5f85731 https://echa.europa.eu/documents/10162/474ba309-ed3f-4b3a-a293-714fa6aafdd0
reaction mass of 5-(sec-butyl)-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-(sec-butyl)-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
413-720-9 117933-89-8 vPvB (Article 57e) 15/06/2015 https://echa.europa.eu/documents/10162/f7c78fc1-bc3e-4913-9a8f-1f57e03326e4 https://echa.europa.eu/documents/10162/c87c2930-58af-20dd-8394-afcd0d96ee3f https://echa.europa.eu/documents/10162/a4fac134-09e6-43c1-a65f-dfaee5f85731 https://echa.europa.eu/documents/10162/474ba309-ed3f-4b3a-a293-714fa6aafdd0
2-(2,4-Dimethylcyclohex-3-ene-1-yl)-5-methyl-(1-methylpropyl)-1,3-dioxane
601-499-3 117933-89-8 vPvB (Article 57e) 15/06/2015 https://echa.europa.eu/documents/10162/f7c78fc1-bc3e-4913-9a8f-1f57e03326e4 https://echa.europa.eu/documents/10162/c87c2930-58af-20dd-8394-afcd0d96ee3f https://echa.europa.eu/documents/10162/a4fac134-09e6-43c1-a65f-dfaee5f85731 https://echa.europa.eu/documents/10162/474ba309-ed3f-4b3a-a293-714fa6aafdd0
Reaction mass of 5-[(2R)-butan-2-yl]-2-[(1R,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1R,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane
700-927-7 - vPvB (Article 57e) 15/06/2015 https://echa.europa.eu/documents/10162/f7c78fc1-bc3e-4913-9a8f-1f57e03326e4 https://echa.europa.eu/documents/10162/c87c2930-58af-20dd-8394-afcd0d96ee3f https://echa.europa.eu/documents/10162/a4fac134-09e6-43c1-a65f-dfaee5f85731 https://echa.europa.eu/documents/10162/474ba309-ed3f-4b3a-a293-714fa6aafdd0
5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
- - vPvB (Article 57e) 15/06/2015 https://echa.europa.eu/documents/10162/f7c78fc1-bc3e-4913-9a8f-1f57e03326e4 https://echa.europa.eu/documents/10162/c87c2930-58af-20dd-8394-afcd0d96ee3f https://echa.europa.eu/documents/10162/a4fac134-09e6-43c1-a65f-dfaee5f85731 https://echa.europa.eu/documents/10162/474ba309-ed3f-4b3a-a293-714fa6aafdd0
5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
- - vPvB (Article 57e) 15/06/2015 https://echa.europa.eu/documents/10162/f7c78fc1-bc3e-4913-9a8f-1f57e03326e4 https://echa.europa.eu/documents/10162/c87c2930-58af-20dd-8394-afcd0d96ee3f https://echa.europa.eu/documents/10162/a4fac134-09e6-43c1-a65f-dfaee5f85731 https://echa.europa.eu/documents/10162/474ba309-ed3f-4b3a-a293-714fa6aafdd0
1,2-benzenedicarboxylic acid, di-C6-10-alkyl esters or mixed decyl and hexyl and octyl diesters with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5) - - Toxic for reproduction (Article 57c) 15/06/2015 https://echa.europa.eu/documents/10162/aa4096ae-2a92-47b6-96c4-8e903234b2ae https://echa.europa.eu/documents/10162/2f94f5c2-0a8c-45dc-b49d-cceab69b9791 https://echa.europa.eu/documents/10162/ac10af03-d3ba-4022-88fc-074de0f5a0df https://echa.europa.eu/documents/10162/b4ee6a0c-35fe-49f6-9315-d29d4c13a458
1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters
272-013-1 68648-93-1 Toxic for reproduction (Article 57c) 15/06/2015 https://echa.europa.eu/documents/10162/aa4096ae-2a92-47b6-96c4-8e903234b2ae https://echa.europa.eu/documents/10162/2f94f5c2-0a8c-45dc-b49d-cceab69b9791 https://echa.europa.eu/documents/10162/ac10af03-d3ba-4022-88fc-074de0f5a0df https://echa.europa.eu/documents/10162/b4ee6a0c-35fe-49f6-9315-d29d4c13a458
1,2-Benzenedicarboxylic acid, di-C6-10-alkyl esters
271-094-0 68515-51-5 Toxic for reproduction (Article 57c) 15/06/2015 https://echa.europa.eu/documents/10162/aa4096ae-2a92-47b6-96c4-8e903234b2ae https://echa.europa.eu/documents/10162/2f94f5c2-0a8c-45dc-b49d-cceab69b9791 https://echa.europa.eu/documents/10162/ac10af03-d3ba-4022-88fc-074de0f5a0df https://echa.europa.eu/documents/10162/b4ee6a0c-35fe-49f6-9315-d29d4c13a458
Reaction mass of 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate and 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (reaction mass of DOTE and MOTE)
- - Toxic for reproduction (Article 57c) 17/12/2014 https://echa.europa.eu/documents/10162/917a0639-8b9d-43ce-802c-b4e82a7f20e3 https://echa.europa.eu/documents/10162/371b4814-2cbd-429d-88b9-905c19d0d299 https://echa.europa.eu/documents/10162/a410b50c-11f9-49ca-9e8f-54f2a674b032 https://echa.europa.eu/documents/10162/e7346212-3697-46cd-abb4-6a77c386e2e6
Cadmium sulphate
233-331-6 10124-36-4, 31119-53-6 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#Toxic for reproduction (Article 57c)#Specific target organ toxicity after repeated exposure (Article 57(f) - human health) 17/12/2014 https://echa.europa.eu/documents/10162/9e3c41d5-088a-47e7-944a-2ccb112493b3 https://echa.europa.eu/documents/10162/bbe26e5b-facf-4668-bc8c-38a175be4c62 https://echa.europa.eu/documents/10162/037ede8d-4f3a-030c-8663-8b04336272ad https://echa.europa.eu/documents/10162/7ae24c0b-474e-4aee-8af9-719d52995eb9
Cadmium fluoride
232-222-0 7790-79-6 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#Toxic for reproduction (Article 57c)#Specific target organ toxicity after repeated exposure (Article 57(f) - human health) 17/12/2014 https://echa.europa.eu/documents/10162/e333469a-fca7-48c2-a88f-52eaa8e7ad7e https://echa.europa.eu/documents/10162/0bba6429-659f-448b-9623-c6737291a3b1 https://echa.europa.eu/documents/10162/6eb02b71-b691-4b53-b0f1-c8c68b2b3083 https://echa.europa.eu/documents/10162/6f01fd3c-e0e6-4f19-be18-855ad6851eb3
2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (DOTE)
239-622-4 15571-58-1 Toxic for reproduction (Article 57c) 17/12/2014 https://echa.europa.eu/documents/10162/8f7e275c-c02c-4357-90d9-59a37b14337a https://echa.europa.eu/documents/10162/0a3e8564-b077-46a7-a90e-2f59f458932f https://echa.europa.eu/documents/10162/04d23d27-3484-48c9-862c-0637e30642a1 https://echa.europa.eu/documents/10162/5121356e-a648-43b5-84d7-a61d8a5817a5
2-benzotriazol-2-yl-4,6-di-tert-butylphenol (UV-320)
223-346-6 3846-71-7 PBT (Article 57d)#vPvB (Article 57e) 17/12/2014 https://echa.europa.eu/documents/10162/27d9317d-3aeb-41d5-9116-1e07696d90cd https://echa.europa.eu/documents/10162/96387d49-cb01-423c-bd6e-927a7b6c434f https://echa.europa.eu/documents/10162/33c375a1-c4de-4f14-a143-cff986175d76 https://echa.europa.eu/documents/10162/a97d26a1-9543-4a7b-b28c-4895895cfd52
2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328)
247-384-8 25973-55-1 PBT (Article 57d)#vPvB (Article 57e) 17/12/2014 https://echa.europa.eu/documents/10162/c6a0c43b-adba-4351-a093-66b36d470de3 https://echa.europa.eu/documents/10162/0ca781ed-adf7-4d40-95b7-a7ea17543f5c https://echa.europa.eu/documents/10162/31f2c070-ad6f-4de9-b17d-402eedb05eac https://echa.europa.eu/documents/10162/52e0db13-91a3-4781-9546-e0fba42a7965
Sodium peroxometaborate
231-556-4 7632-04-4 Toxic for reproduction (Article 57c) 16/06/2014 https://echa.europa.eu/documents/10162/55e1c126-a528-440f-8c10-49a31b82eda3 https://echa.europa.eu/documents/10162/59b315b3-efb1-4ffa-b4bb-3c2c1259da45 https://echa.europa.eu/documents/10162/46e192c7-457f-43fc-b93f-14d2ce0347f9 https://echa.europa.eu/documents/10162/7e77bc4b-2d4a-4810-808e-6b77135a1e51
Sodium perborate, perboric acid, sodium salt
- - Toxic for reproduction (Article 57c) 16/06/2014 https://echa.europa.eu/documents/10162/02bff80c-33f6-4995-a1ef-4a7c33825069 https://echa.europa.eu/documents/10162/a613b801-a38f-4924-a821-20422b5dc34c https://echa.europa.eu/documents/10162/c0c32de2-a83b-4486-ad07-26303bb8bb0d https://echa.europa.eu/documents/10162/f6784d7d-f1c9-47a3-b401-f7f363c6c4cb
Sodium perborate
239-172-9 15120-21-5 Toxic for reproduction (Article 57c) 16/06/2014 https://echa.europa.eu/documents/10162/02bff80c-33f6-4995-a1ef-4a7c33825069 https://echa.europa.eu/documents/10162/a613b801-a38f-4924-a821-20422b5dc34c https://echa.europa.eu/documents/10162/c0c32de2-a83b-4486-ad07-26303bb8bb0d https://echa.europa.eu/documents/10162/f6784d7d-f1c9-47a3-b401-f7f363c6c4cb
Perboric acid, sodium salt
234-390-0 11138-47-9 Toxic for reproduction (Article 57c) 16/06/2014 https://echa.europa.eu/documents/10162/02bff80c-33f6-4995-a1ef-4a7c33825069 https://echa.europa.eu/documents/10162/a613b801-a38f-4924-a821-20422b5dc34c https://echa.europa.eu/documents/10162/c0c32de2-a83b-4486-ad07-26303bb8bb0d https://echa.europa.eu/documents/10162/f6784d7d-f1c9-47a3-b401-f7f363c6c4cb
Cadmium chloride
233-296-7 10108-64-2 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#Toxic for reproduction (Article 57c)#Specific target organ toxicity after repeated exposure (Article 57(f) - human health) 16/06/2014 https://echa.europa.eu/documents/10162/e2bc867c-de85-4d6d-a9d6-d856ab51685c https://echa.europa.eu/documents/10162/a7d0fcf7-deb2-402e-af3b-c3b1759615f9 https://echa.europa.eu/documents/10162/a210c4dd-6ef4-4f76-9fd9-5b35a7482c1b https://echa.europa.eu/documents/10162/64588778-b451-427b-951c-679367411297
1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear
271-093-5 68515-50-4 Toxic for reproduction (Article 57c) 16/06/2014 https://echa.europa.eu/documents/10162/34533e6e-84d2-4a40-815d-7a02dac17041 https://echa.europa.eu/documents/10162/4ffa71cf-34d5-4968-9b46-58d2398a211a https://echa.europa.eu/documents/10162/f2fc61d4-7e23-4a9a-a52d-10ae36e9987e https://echa.europa.eu/documents/10162/44b5afac-f7be-45af-853b-6c05cc445908
Trixylyl phosphate
246-677-8 25155-23-1 Toxic for reproduction (Article 57c) 16/12/2013 https://echa.europa.eu/documents/10162/464f639f-6e07-4966-b63a-081ac8040e63 https://echa.europa.eu/documents/10162/e764d667-57dc-4956-8628-6245f36d5552 https://echa.europa.eu/documents/10162/aa428e86-ed97-4450-8e78-cdbb06e46c8f https://echa.europa.eu/documents/10162/ffb00bd9-6e1c-4cfc-b4b1-39682e205ab9
Lead di(acetate)
206-104-4 301-04-2 Toxic for reproduction (Article 57c) 16/12/2013 https://echa.europa.eu/documents/10162/ff4184dc-c595-4dc8-8241-941c073f2221 https://echa.europa.eu/documents/10162/86ace337-8153-47fb-b0b0-8193c621c433 https://echa.europa.eu/documents/10162/49fa197b-8a06-4d92-abf4-f40ad0a6f815 https://echa.europa.eu/documents/10162/19c550f8-a60f-4273-8886-8e6e7a3b7f67
Imidazolidine-2-thione (2-imidazoline-2-thiol)
202-506-9 96-45-7 Toxic for reproduction (Article 57c) 16/12/2013 https://echa.europa.eu/documents/10162/e01d8301-5596-4905-98ad-f17eb9455241 https://echa.europa.eu/documents/10162/85a2311e-2252-4f8a-b987-451846cee286 https://echa.europa.eu/documents/10162/24751f9c-5206-4190-bcc9-3ca9418e0e31 https://echa.europa.eu/documents/10162/32a66ff7-87cd-4434-9958-840fbc44853d
Disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo] -5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate (C.I. Direct Black 38)
217-710-3 1937-37-7 Carcinogenic (Article 57a) 16/12/2013 https://echa.europa.eu/documents/10162/6ab9d8cb-2d82-4dba-a68b-8752a00c4c76 https://echa.europa.eu/documents/10162/d04de1ae-26e0-45ac-969c-259a0cdd5338 https://echa.europa.eu/documents/10162/ef1f3daa-fc8b-4bf5-8bd1-71e80a2adf62 https://echa.europa.eu/documents/10162/0e04be91-d3fe-4bcd-9d4d-a13600188e99
Disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate) (C.I. Direct Red 28)
209-358-4 573-58-0 Carcinogenic (Article 57a) 16/12/2013 https://echa.europa.eu/documents/10162/f9d799e8-5a32-44d1-b383-4c9695085cbf https://echa.europa.eu/documents/10162/fd83a2e5-21ca-4ec4-a4d2-2465637f90c0 https://echa.europa.eu/documents/10162/cf3a4398-3305-424e-ab1e-a02fbc548431 https://echa.europa.eu/documents/10162/110c524e-6b26-4a2c-8241-a16921df7927
Dihexyl phthalate
201-559-5 84-75-3 Toxic for reproduction (Article 57c) 16/12/2013 https://echa.europa.eu/documents/10162/d90bb47a-7e33-43c3-82ad-18a55d39d502 https://echa.europa.eu/documents/10162/eecf78d5-f23d-44b0-a3db-0357c698ae4b https://echa.europa.eu/documents/10162/65336c46-c178-4b71-a927-15437e8b303a https://echa.europa.eu/documents/10162/6fe33a79-79d9-41cb-bf52-4f7b8f7f2f4d
Cadmium sulphide
215-147-8 1306-23-6 Carcinogenic (Article 57a)#Specific target organ toxicity after repeated exposure (Article 57(f) - human health) 16/12/2013 https://echa.europa.eu/documents/10162/204bc9fa-0673-4753-bd0e-e3503b4a1956 https://echa.europa.eu/documents/10162/f30a9a9a-9ce1-429e-96fb-7f24fe4de850 https://echa.europa.eu/documents/10162/2aceee75-6b50-416c-aa30-d3131c5eeee3 https://echa.europa.eu/documents/10162/5f847fab-5b4d-43da-a220-53ac8280464f
Pentadecafluorooctanoic acid (PFOA)
206-397-9 335-67-1 Toxic for reproduction (Article 57c)#PBT (Article 57d) 20/06/2013 https://echa.europa.eu/documents/10162/092663e6-b14a-4a06-aadf-fc0e56bc0a23 https://echa.europa.eu/documents/10162/facda3f9-a050-4f29-91f1-358175b67a39 https://echa.europa.eu/documents/10162/8059e342-1092-410f-bd85-80118a5526f5 https://echa.europa.eu/documents/10162/72da5f74-b997-4bb0-82c1-d5c4b9d907e8
Dipentyl phthalate (DPP)
205-017-9 131-18-0 Toxic for reproduction (Article 57c) 20/06/2013 https://echa.europa.eu/documents/10162/365998db-beb8-47b6-b080-ca5549397cd9 https://echa.europa.eu/documents/10162/8a80cf7b-cce9-4152-89f4-e8ad58ce6fde https://echa.europa.eu/documents/10162/11bbf18f-02ac-4b12-a715-056df904057c https://echa.europa.eu/documents/10162/42b8e525-017e-49b0-b50b-00ed05e4bd00
Cadmium oxide
215-146-2 1306-19-0 Carcinogenic (Article 57a)#Specific target organ toxicity after repeated exposure (Article 57(f) - human health) 20/06/2013 https://echa.europa.eu/documents/10162/2fb75d7e-485c-4edb-8c72-4204f224bbca https://echa.europa.eu/documents/10162/a03b1b4e-3090-455e-9cb0-1dc52005f7c0 https://echa.europa.eu/documents/10162/f09f23c5-98fc-4e56-abc2-feae96de0f3d https://echa.europa.eu/documents/10162/6bf65619-acc3-480a-b8ca-3c002f6e20d8
Cadmium
231-152-8 7440-43-9 Carcinogenic (Article 57a)#Specific target organ toxicity after repeated exposure (Article 57(f) - human health) 20/06/2013 https://echa.europa.eu/documents/10162/49a335ae-1ec4-40e5-88fb-3b08702da95c https://echa.europa.eu/documents/10162/b252eefb-8012-46bb-8a47-74ff66a0a8d4 https://echa.europa.eu/documents/10162/a048359b-de39-4b7e-8602-51272a55aeae https://echa.europa.eu/documents/10162/9731cc85-9740-47ac-a489-0142f38a6956
Ammonium pentadecafluorooctanoate (APFO)
223-320-4 3825-26-1 Toxic for reproduction (Article 57c)#PBT (Article 57d) 20/06/2013 https://echa.europa.eu/documents/10162/b06436fd-6367-4a2f-b6a2-2b8ffa183ae9 https://echa.europa.eu/documents/10162/df602a5b-2df3-490f-ad1c-e2e782ad7dc9 https://echa.europa.eu/documents/10162/5e2c1e53-be98-4104-8b96-9cd88655a92a https://echa.europa.eu/documents/10162/f9c062a6-fd64-475d-98c3-58017cf579ce
4-Nonylphenol, branched and linear, ethoxylated substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof - - Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethanol
230-770-5 7311-27-5 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
26-(4-nonylphenoxy)-3,6,9,12,15,18,21,24-Octaoxahexacosan-1-ol
604-395-6 14409-72-4 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
2-[2-(4-nonylphenoxy)ethoxy]ethanol
243-816-4 20427-84-3 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Nonylphenol, branched, ethoxylated 1 - 2.5 moles ethoxylated 500-209-1 68412-54-4 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
4-Nonylphenol, ethoxylated 1 - 2.5 moles ethoxylated 500-045-0 26027-38-3 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Nonylphenol, ethoxylated (8-EO) (9016-45-9)
931-754-7 - Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Nonylphenol, branched, ethoxylated (CAS# 68412-54-4)
932-688-1 - Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Nonylphenol, ethoxylated (15-EO) (9016-45-9)
931-756-8 - Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Nonylphenol, ethoxylated (10-EO) (9016-45-9)
931-755-2 - Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
20-(4-nonylphenoxy)-3,6,9,12,15,18-hexaoxaicosan-1-ol
248-743-1 27942-27-4 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Nonylphenol, ethoxylated (6,5-EO) (9016-45-9)
931-753-1 - Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Nonylphenol, ethoxylated
500-024-6 9016-45-9 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Nonylphenol, ethoxylated (EO = 10)
939-993-9 - Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Nonylphenol, ethoxylated (EO = 4)
939-975-0 - Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Nonylphenol, ethoxylated (polymer)
938-618-6 - Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
2-{2-[4-(3,6-dimethylheptan-3-yl)phenoxy]ethoxy}ethanol
687-833-9 1119449-38-5 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
2-[4-(3,6-dimethylheptan-3-yl)phenoxy]ethanol
687-832-3 1119449-37-4 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Nonylphenolpolyglycolether
932-998-7 - Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Poly(oxy-1,2-ethanediyl), a-(nonylphenyl)-w-hydroxy- (CAS 9016-45-9)
931-562-3 9016-45-9 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Isononylphenol, ethoxylated
609-346-2 37205-87-1 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
4-Nonylphenol, branched, ethoxylated 1 - 2.5 moles ethoxylated 500-315-8 127087-87-0 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol
247-816-5 26571-11-9 Endocrine disrupting properties (Article 57(f) - environment) 20/06/2013 https://echa.europa.eu/documents/10162/fd80f890-fb73-4201-8e2f-06dc04eaf5a9 https://echa.europa.eu/documents/10162/90d219f2-cd83-4e2b-bb9e-3ed6d5ff91bf https://echa.europa.eu/documents/10162/9af34d5f-cd2f-4e63-859c-529bb39da7ae#https://echa.europa.eu/documents/10162/38d2e3f0-2449-4767-97a4-6b5f5db56aef https://echa.europa.eu/documents/10162/3b9a5671-cf03-4542-adbb-cf15e0b0696b
Trilead dioxide phosphonate
235-252-2 12141-20-7 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/af3610a5-f180-4fcd-95b7-636e43da9198 https://echa.europa.eu/documents/10162/57804b85-bfe3-4fb3-ba6e-85681ae9a946 https://echa.europa.eu/documents/10162/0b3bffdb-ee49-4d1d-9ef7-7e1aeed13818 https://echa.europa.eu/documents/10162/551628e8-85c8-4637-bfd0-b59e03511a93
Trilead bis(carbonate) dihydroxide
215-290-6 1319-46-6 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/bd13bb56-cf5a-4eee-b7a2-367ba3838e86 https://echa.europa.eu/documents/10162/e8388e88-796e-48d6-b857-92e1de8cba7b https://echa.europa.eu/documents/10162/c05a327c-bc4e-4b7f-84cf-15e52804e50f https://echa.europa.eu/documents/10162/37a723d0-dd88-40de-9bb5-6e5b0fbd0537
Tricosafluorododecanoic acid
206-203-2 307-55-1 vPvB (Article 57e) 19/12/2012 https://echa.europa.eu/documents/10162/dd827b99-e744-4d49-84c3-00b82732059b https://echa.europa.eu/documents/10162/10982bb6-eb4f-4b49-8ae2-934e051c4227 https://echa.europa.eu/documents/10162/0d5abffa-6bbf-40c7-b6b1-1ca3736cf570 https://echa.europa.eu/documents/10162/27794cc1-9628-4c99-95b6-eb9acf456c6c
Tetralead trioxide sulphate
235-380-9 12202-17-4 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/f56110e1-a0d6-4a1e-8c7d-9940d5ec8d91 https://echa.europa.eu/documents/10162/08f78ab7-6708-418d-ab77-adf1100ab429 https://echa.europa.eu/documents/10162/735b9afe-5a6a-41d2-9b7b-7758ec3c5702 https://echa.europa.eu/documents/10162/8dfa30e0-eba5-44b4-93ad-36f20c6b712f
Tetraethyllead
201-075-4 78-00-2 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/0b417b76-b533-42a1-9bd2-519f1dc1990d https://echa.europa.eu/documents/10162/118d71ba-5734-45ac-9dfe-ab74edca7803 https://echa.europa.eu/documents/10162/136a8d6e-ebac-4000-8183-ad9176fd134b https://echa.europa.eu/documents/10162/07e61c3c-175f-488d-a4d7-749b4566fd0c
Sulfurous acid, lead salt, dibasic
263-467-1 62229-08-7 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/486d5d7c-c872-48cf-9392-e86ecff34c04 https://echa.europa.eu/documents/10162/44b75647-0300-4836-a312-f11ba9574ece https://echa.europa.eu/documents/10162/cc6c0ca7-538e-4a5b-88fe-b1a635241a45 https://echa.europa.eu/documents/10162/ba3e823e-bc52-4bbf-a676-c5717d629f60
Silicic acid, lead salt
234-363-3 11120-22-2 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/a7314719-5b08-47ef-9ee7-daca71e06f54 https://echa.europa.eu/documents/10162/8a921407-3b0f-471a-a684-131dfba77523 https://echa.europa.eu/documents/10162/512e9d72-d0f3-4e3b-a0a6-a6a642c5d2d0 https://echa.europa.eu/documents/10162/9709ec20-cbed-450d-98ce-a92dd704b03b
Silicic acid (H2Si2O5), barium salt (1:1), lead-doped with lead (Pb) content above the applicable generic concentration limit for ’toxicity for reproduction’ Repr. 1A (CLP) or category 1 (DSD),the substance is a member of the group entry of lead compounds, with index number 082-001-00-6 in Regulation (EC) No 1272/2008 272-271-5 68784-75-8 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/6bd3a623-dcbc-43ff-a5fa-8f710fc4053b https://echa.europa.eu/documents/10162/d0de0c48-5768-4589-8dd4-dbcafce8e7dd https://echa.europa.eu/documents/10162/b8793a13-a6e6-40e8-bdb8-eff69444b232 https://echa.europa.eu/documents/10162/fdf8725e-646e-4805-b2f2-42e4be27b813
Pyrochlore, antimony lead yellow - 232-382-1 8012-00-8 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/9e101a56-02e0-481f-babb-e4f62d36912b https://echa.europa.eu/documents/10162/3da568db-d1e1-4082-b0c7-78246ccb1489 https://echa.europa.eu/documents/10162/1014fa88-d28e-4385-8530-fe2c38032c27 https://echa.europa.eu/documents/10162/5f309597-48fa-4f15-86e3-fe8099ebef10
Pentalead tetraoxide sulphate
235-067-7 12065-90-6 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/664946a7-1fba-487d-8d28-f47de7fb3a5c https://echa.europa.eu/documents/10162/adc19a74-9ef0-4920-93c5-0b25d600b8c4 https://echa.europa.eu/documents/10162/5a790e77-efd4-4c56-84bb-b00a92b732b4 https://echa.europa.eu/documents/10162/02a96361-edc4-490e-8766-d2f2895f27c1
Pentacosafluorotridecanoic acid
276-745-2 72629-94-8 vPvB (Article 57e) 19/12/2012 https://echa.europa.eu/documents/10162/0df4a67b-03ac-4468-b6b5-6526237f92ba https://echa.europa.eu/documents/10162/111dde32-185d-4e50-9112-5c1c019b920a https://echa.europa.eu/documents/10162/3fd11ee9-6925-475f-b328-d224d45219a4 https://echa.europa.eu/documents/10162/401632cf-1ca1-41c0-bc62-c2a5290cec21
Orange lead (lead tetroxide)
215-235-6 1314-41-6 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/97af2122-f294-472c-9cc8-978f116c6929 https://echa.europa.eu/documents/10162/aab36e2a-90e2-46b0-b940-07e4cf119f05 https://echa.europa.eu/documents/10162/1bfc12f4-bbce-4df6-aa60-e22fc0e1a5e0 https://echa.europa.eu/documents/10162/3906f21f-91f9-4693-85c9-d959cca7e315
o-toluidine
202-429-0 95-53-4 Carcinogenic (Article 57a) 19/12/2012 https://echa.europa.eu/documents/10162/953517bb-4055-4a5b-9ed7-4bb69c3b96e7 https://echa.europa.eu/documents/10162/c4e9db39-8285-48d9-87b3-29c15c861802 https://echa.europa.eu/documents/10162/2963ade6-f093-4c8c-b9b2-604f538a3131 https://echa.europa.eu/documents/10162/433aca4f-bd72-4a1e-92c4-ecbb2b8e4dbb
o-aminoazotoluene
202-591-2 97-56-3 Carcinogenic (Article 57a) 19/12/2012 https://echa.europa.eu/documents/10162/d7aaf254-b61a-48a2-9f03-9c49bd0164c1 https://echa.europa.eu/documents/10162/d1a365c6-34d1-4fda-81c7-09c7f4b07a77 https://echa.europa.eu/documents/10162/b94dedbc-8af4-4223-b68e-fcddccee3119 https://echa.europa.eu/documents/10162/54d7da21-c643-4f2f-bd49-160930e71491
n-pentyl-isopentylphthalate
933-378-9 - Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/d54fc5db-a2c6-4b1c-9000-e398645ad294 https://echa.europa.eu/documents/10162/c33869fc-43f1-44c2-812f-0c6ad82104c6 https://echa.europa.eu/documents/10162/73ef6184-8578-44dc-ac23-8034f1db5471 https://echa.europa.eu/documents/10162/1a5100be-06a0-45cf-b5f1-18e0bc4b3b42
N-methylacetamide
201-182-6 79-16-3 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/2d6d4c98-5c55-41ff-89e0-6557aed1c003 https://echa.europa.eu/documents/10162/cd5a3079-1069-4f2f-815c-a628714f76a7 https://echa.europa.eu/documents/10162/df25f106-5e4c-4f4b-baed-fc2251e9d233 https://echa.europa.eu/documents/10162/8e13f7b0-ae4d-4362-8ae1-cb9b22d9433c
N,N-dimethylformamide
200-679-5 68-12-2 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/52c73750-c192-457c-9c48-2bd9776cec88 https://echa.europa.eu/documents/10162/e3a1814f-6a8c-4c02-858e-74f98d525824 https://echa.europa.eu/documents/10162/3f575bea-5a96-4f18-a110-d294d37422c7 https://echa.europa.eu/documents/10162/cdf0e5c6-ad40-48b8-bb8b-414278327567
Methyloxirane (Propylene oxide)
200-879-2 75-56-9 Carcinogenic (Article 57a)#Mutagenic (Article 57b) 19/12/2012 https://echa.europa.eu/documents/10162/005a9afb-2a53-41df-8711-5c28765c6e6b https://echa.europa.eu/documents/10162/38636e85-49ef-4b37-890c-65ba488e7521 https://echa.europa.eu/documents/10162/b7acbd05-555e-4133-9dd6-130206c4088b https://echa.europa.eu/documents/10162/145764d1-cca8-40f6-81a7-a89de5a5c54b
Methoxyacetic acid
210-894-6 625-45-6 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/afb7a0e1-9222-4385-88cf-71c0b06191d0 https://echa.europa.eu/documents/10162/2a9e3fcd-2243-4357-b837-9532235a307f https://echa.europa.eu/documents/10162/e2dffe7e-49be-4dc6-b155-ecf3b91f42b7 https://echa.europa.eu/documents/10162/f4b39663-36ed-4754-9de3-35db3eaa94d5
Lead titanium zirconium oxide
235-727-4 12626-81-2 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/01818c6d-bcc9-4136-9eec-888823ae5fb0 https://echa.europa.eu/documents/10162/b655b355-0ced-4795-a2d2-76c912c7acca https://echa.europa.eu/documents/10162/ce330db6-0bef-4df9-82f6-b9d44060d28c https://echa.europa.eu/documents/10162/d7b5e532-675e-46a7-8df5-4b15797059a3
Lead titanium trioxide
235-038-9 12060-00-3 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/933f22c2-cfa6-4126-b0a5-3ba33ce75487 https://echa.europa.eu/documents/10162/d69baa79-6ed9-4c3e-9aed-584577c19696 https://echa.europa.eu/documents/10162/1122f98c-4515-4a5b-98b5-f864d9f1979b https://echa.europa.eu/documents/10162/fb33762a-9244-4e5d-b34f-2efe3d74eccf
Lead oxide sulfate
234-853-7 12036-76-9 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/23bfbbe6-9985-42fe-b401-a7df81ec12cc https://echa.europa.eu/documents/10162/50822d59-490c-4e01-88c3-c8ff8d2d389a https://echa.europa.eu/documents/10162/0362e7d9-bcb5-41bc-945c-19365594480f https://echa.europa.eu/documents/10162/08869a9e-cd0e-4f83-9fed-4eed067bb1cb
Lead monoxide (lead oxide)
215-267-0 1317-36-8 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/ea71029e-f8de-4e5d-a393-6961aefd6e14 https://echa.europa.eu/documents/10162/86c143a2-eb69-44bd-9710-73ab2aca57fc https://echa.europa.eu/documents/10162/a2a8c72d-c0ed-4d92-a89c-26ae4ccd35e9 https://echa.europa.eu/documents/10162/3519ec10-ee76-466a-8a01-8ba0c6d43c16
Lead dinitrate
233-245-9 10099-74-8 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/e1c55ba4-1f9a-4633-b4c3-fdaba005b095 https://echa.europa.eu/documents/10162/97c17507-b6bc-42d7-8aac-59c0c0e9c21b https://echa.europa.eu/documents/10162/be34d0ca-8d1e-488f-8b49-35063b0054b3 https://echa.europa.eu/documents/10162/44258a5f-9de8-41b6-ac6d-8060b65a9e42
Lead cyanamidate
244-073-9 20837-86-9 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/a6f8212c-590f-469a-b6c1-f40f234e4518 https://echa.europa.eu/documents/10162/0225706b-6dbf-4b6f-94f8-fa3e8fc24ff6 https://echa.europa.eu/documents/10162/7f3131c3-b63f-49e8-9717-68dc7883b549 https://echa.europa.eu/documents/10162/2847646f-4f4d-4478-99a7-4dbfbd6095bb
Lead bis(tetrafluoroborate)
237-486-0 13814-96-5 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/56f43ea4-a623-4d5e-b741-fee1fef7e771 https://echa.europa.eu/documents/10162/0d9b7449-9ec1-4c1e-a117-294cccc4aa9d https://echa.europa.eu/documents/10162/97eb15e6-b3ba-4d3f-9b02-368642962b63 https://echa.europa.eu/documents/10162/5fd6563e-33b1-4f42-be2e-b0ebc8fc1e54
Hexahydromethylphthalic anhydride including cis- and trans- stereo isomeric forms and all possible combinations of the isomers - - Respiratory sensitising properties (Article 57(f) - human health) 19/12/2012 https://echa.europa.eu/documents/10162/81052549-dd49-40b5-9388-b5a72a1a3fb3 https://echa.europa.eu/documents/10162/bd282c4d-91b6-4537-9f27-b65a5fccbd48#https://echa.europa.eu/documents/10162/670b8e64-298e-4ed7-939f-67da04164a42#https://echa.europa.eu/documents/10162/7e96ce49-1e77-4333-8e0e-35892531aa5c#https://echa.europa.eu/documents/10162/081b759a-1aae-42d9-9f62-4051fb9187bc https://echa.europa.eu/documents/10162/3ee8978c-40be-4dc4-a12d-798caf6424f0 https://echa.europa.eu/documents/10162/529bafce-9751-409d-84c5-607943a71bc0
Hexahydro-4-methylphthalic anhydride
243-072-0 19438-60-9 Respiratory sensitising properties (Article 57(f) - human health) 19/12/2012 https://echa.europa.eu/documents/10162/81052549-dd49-40b5-9388-b5a72a1a3fb3 https://echa.europa.eu/documents/10162/bd282c4d-91b6-4537-9f27-b65a5fccbd48#https://echa.europa.eu/documents/10162/670b8e64-298e-4ed7-939f-67da04164a42#https://echa.europa.eu/documents/10162/7e96ce49-1e77-4333-8e0e-35892531aa5c#https://echa.europa.eu/documents/10162/081b759a-1aae-42d9-9f62-4051fb9187bc https://echa.europa.eu/documents/10162/3ee8978c-40be-4dc4-a12d-798caf6424f0 https://echa.europa.eu/documents/10162/529bafce-9751-409d-84c5-607943a71bc0
Hexahydro-3-methylphthalic anhydride
260-566-1 57110-29-9 Respiratory sensitising properties (Article 57(f) - human health) 19/12/2012 https://echa.europa.eu/documents/10162/81052549-dd49-40b5-9388-b5a72a1a3fb3 https://echa.europa.eu/documents/10162/bd282c4d-91b6-4537-9f27-b65a5fccbd48#https://echa.europa.eu/documents/10162/670b8e64-298e-4ed7-939f-67da04164a42#https://echa.europa.eu/documents/10162/7e96ce49-1e77-4333-8e0e-35892531aa5c#https://echa.europa.eu/documents/10162/081b759a-1aae-42d9-9f62-4051fb9187bc https://echa.europa.eu/documents/10162/3ee8978c-40be-4dc4-a12d-798caf6424f0 https://echa.europa.eu/documents/10162/529bafce-9751-409d-84c5-607943a71bc0
Hexahydro-1-methylphthalic anhydride
256-356-4 48122-14-1 Respiratory sensitising properties (Article 57(f) - human health) 19/12/2012 https://echa.europa.eu/documents/10162/81052549-dd49-40b5-9388-b5a72a1a3fb3 https://echa.europa.eu/documents/10162/bd282c4d-91b6-4537-9f27-b65a5fccbd48#https://echa.europa.eu/documents/10162/670b8e64-298e-4ed7-939f-67da04164a42#https://echa.europa.eu/documents/10162/7e96ce49-1e77-4333-8e0e-35892531aa5c#https://echa.europa.eu/documents/10162/081b759a-1aae-42d9-9f62-4051fb9187bc https://echa.europa.eu/documents/10162/3ee8978c-40be-4dc4-a12d-798caf6424f0 https://echa.europa.eu/documents/10162/529bafce-9751-409d-84c5-607943a71bc0
Hexahydromethylphthalic anhydride
247-094-1 25550-51-0 Respiratory sensitising properties (Article 57(f) - human health) 19/12/2012 https://echa.europa.eu/documents/10162/81052549-dd49-40b5-9388-b5a72a1a3fb3 https://echa.europa.eu/documents/10162/bd282c4d-91b6-4537-9f27-b65a5fccbd48#https://echa.europa.eu/documents/10162/670b8e64-298e-4ed7-939f-67da04164a42#https://echa.europa.eu/documents/10162/7e96ce49-1e77-4333-8e0e-35892531aa5c#https://echa.europa.eu/documents/10162/081b759a-1aae-42d9-9f62-4051fb9187bc https://echa.europa.eu/documents/10162/3ee8978c-40be-4dc4-a12d-798caf6424f0 https://echa.europa.eu/documents/10162/529bafce-9751-409d-84c5-607943a71bc0
Heptacosafluorotetradecanoic acid
206-803-4 376-06-7 vPvB (Article 57e) 19/12/2012 https://echa.europa.eu/documents/10162/bb2caa51-1bcc-407b-b587-91d4ac23b564 https://echa.europa.eu/documents/10162/de2ad408-ea06-484e-9015-ac6af581863c https://echa.europa.eu/documents/10162/997efe1b-0564-4ca1-a012-bab93e518f25 https://echa.europa.eu/documents/10162/67c973ff-d4cd-406e-97ee-eb89fd779d06
Henicosafluoroundecanoic acid
218-165-4 2058-94-8 vPvB (Article 57e) 19/12/2012 https://echa.europa.eu/documents/10162/02881bec-75ad-4e83-a9bb-c9f6dc81042e https://echa.europa.eu/documents/10162/60adb1fb-d001-4a2a-b8bf-a0e05e29d156 https://echa.europa.eu/documents/10162/01986fb8-ede8-4458-b54e-12ff8a534b98 https://echa.europa.eu/documents/10162/1debbb8c-fd4f-456f-b700-a48bb014e293
Furan
203-727-3 110-00-9 Carcinogenic (Article 57a) 19/12/2012 https://echa.europa.eu/documents/10162/1986ed9a-a382-4409-8faf-abd0f9af440a https://echa.europa.eu/documents/10162/f2a41a5f-68db-44e9-a925-2446de4ec9b1 https://echa.europa.eu/documents/10162/8ab8b38b-26e8-49b7-9f04-b83c457023ec https://echa.europa.eu/documents/10162/f34c251e-40c4-4120-ba3b-13f091aab6db
Fatty acids, C16-18, lead salts
292-966-7 91031-62-8 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/7f59b681-ee89-484b-bec2-3412f3f7d0e5 https://echa.europa.eu/documents/10162/575f1c14-49f5-4a3d-9368-ebbb989edcf4 https://echa.europa.eu/documents/10162/13e375d0-709b-4203-b851-7cb5e0a87c80 https://echa.europa.eu/documents/10162/c93cbfc7-5881-4080-a61c-5a0b5aabffe0
Dioxobis(stearato)trilead
235-702-8 12578-12-0 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/b3332ac2-958d-4b79-86be-12a13f9cd8c8 https://echa.europa.eu/documents/10162/2b533763-b36b-481c-a7b2-ff28b898d343 https://echa.europa.eu/documents/10162/01088b8d-0195-44cf-8760-f1797c18e789 https://echa.europa.eu/documents/10162/61748739-b9eb-4f51-81c8-721c8f24602d
Dinoseb (6-sec-butyl-2,4-dinitrophenol)
201-861-7 88-85-7 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/b23de2c1-7142-43ec-9fba-ee150ed98bb1 https://echa.europa.eu/documents/10162/876747a8-aa98-42f4-bf6c-7ca2be3fed59 https://echa.europa.eu/documents/10162/34ec55f2-27d2-47d6-94f1-d39acaf3634f https://echa.europa.eu/documents/10162/791ab610-ceeb-4caf-b355-aad194a809ac
Dimethyl sulphate
201-058-1 77-78-1 Carcinogenic (Article 57a) 19/12/2012 https://echa.europa.eu/documents/10162/40a80d81-ac48-4ce6-891c-53b7a3779646 https://echa.europa.eu/documents/10162/5182ed44-1e76-4374-898d-0e8cef94f7cb https://echa.europa.eu/documents/10162/8fcaf1f0-ea6d-4ec8-a129-f0405def7c33 https://echa.europa.eu/documents/10162/8dcaa4e9-0029-4544-956b-2167c66a4a16
Diisopentyl phthalate
210-088-4 605-50-5 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/917ec7f1-d611-4dad-8cf7-36c1ca07a400 https://echa.europa.eu/documents/10162/cf490b69-0c28-453b-a531-e8c2ad32d22c https://echa.europa.eu/documents/10162/34d906a5-2558-4faa-ba85-65a765aef016 https://echa.europa.eu/documents/10162/b4b41ba8-517f-473e-89de-c29366270ea4
Diethyl sulphate
200-589-6 64-67-5 Carcinogenic (Article 57a)#Mutagenic (Article 57b) 19/12/2012 https://echa.europa.eu/documents/10162/3f6a4989-b155-4827-abfc-51e3fa7e352d https://echa.europa.eu/documents/10162/296efee3-75ed-4ead-a79c-28a3f48d2d90 https://echa.europa.eu/documents/10162/470b7f44-e538-40b0-9110-4575a5726d14 https://echa.europa.eu/documents/10162/8b9f4aa0-1af0-4770-994c-6a82fdfa51c4
Dibutyltin dichloride (DBTC)
211-670-0 683-18-1 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/046189d5-908b-447f-b91b-b3f97c9de5b5 https://echa.europa.eu/documents/10162/f06ebc42-a92c-43a4-828a-a7c95ea2c961 https://echa.europa.eu/documents/10162/475485b0-e008-4c46-9941-ec1e303f1875 https://echa.europa.eu/documents/10162/838359e4-d249-44f7-a6cc-c2079fdf4521
Diazene-1,2-dicarboxamide (C,C'-azodi(formamide)) (ADCA)
204-650-8 123-77-3 Respiratory sensitising properties (Article 57(f) - human health) 19/12/2012 https://echa.europa.eu/documents/10162/4739d799-2888-4031-b3eb-73a9d475347b https://echa.europa.eu/documents/10162/055d66a6-9924-4386-900c-62c52c42bc62 https://echa.europa.eu/documents/10162/084829ac-52db-478f-8c2c-8ec86527730a https://echa.europa.eu/documents/10162/3d0a4c25-4b8a-46e8-9d54-db365469c40d
Cyclohexane-1,2-dicarboxylic anhydride all possible combinations of the cis- and trans-isomers - - Respiratory sensitising properties (Article 57(f) - human health) 19/12/2012 https://echa.europa.eu/documents/10162/b7a93309-0b81-4dbf-90e0-859bc0f41ce4 https://echa.europa.eu/documents/10162/542f4e26-c203-4587-a498-fbf33c9edeba#https://echa.europa.eu/documents/10162/d0d33d3f-8361-48a5-b5a9-5db91928b4c5#https://echa.europa.eu/documents/10162/dca0c593-37d7-4257-9ad9-14059e525771 https://echa.europa.eu/documents/10162/fafcabed-53a7-4847-b0d6-c5243c7a6ceb https://echa.europa.eu/documents/10162/e1af509e-7b16-43bd-b0f3-d066120d55ad
Cyclohexane-1,2-dicarboxylic anhydride
201-604-9 85-42-7 Respiratory sensitising properties (Article 57(f) - human health) 19/12/2012 https://echa.europa.eu/documents/10162/b7a93309-0b81-4dbf-90e0-859bc0f41ce4 https://echa.europa.eu/documents/10162/542f4e26-c203-4587-a498-fbf33c9edeba#https://echa.europa.eu/documents/10162/d0d33d3f-8361-48a5-b5a9-5db91928b4c5#https://echa.europa.eu/documents/10162/dca0c593-37d7-4257-9ad9-14059e525771 https://echa.europa.eu/documents/10162/fafcabed-53a7-4847-b0d6-c5243c7a6ceb https://echa.europa.eu/documents/10162/e1af509e-7b16-43bd-b0f3-d066120d55ad
trans-cyclohexane-1,2-dicarboxylic anhydride
238-009-9 14166-21-3 Respiratory sensitising properties (Article 57(f) - human health) 19/12/2012 https://echa.europa.eu/documents/10162/b7a93309-0b81-4dbf-90e0-859bc0f41ce4 https://echa.europa.eu/documents/10162/542f4e26-c203-4587-a498-fbf33c9edeba#https://echa.europa.eu/documents/10162/d0d33d3f-8361-48a5-b5a9-5db91928b4c5#https://echa.europa.eu/documents/10162/dca0c593-37d7-4257-9ad9-14059e525771 https://echa.europa.eu/documents/10162/fafcabed-53a7-4847-b0d6-c5243c7a6ceb https://echa.europa.eu/documents/10162/e1af509e-7b16-43bd-b0f3-d066120d55ad
cis-cyclohexane-1,2-dicarboxylic anhydride
236-086-3 13149-00-3 Respiratory sensitising properties (Article 57(f) - human health) 19/12/2012 https://echa.europa.eu/documents/10162/b7a93309-0b81-4dbf-90e0-859bc0f41ce4 https://echa.europa.eu/documents/10162/542f4e26-c203-4587-a498-fbf33c9edeba#https://echa.europa.eu/documents/10162/d0d33d3f-8361-48a5-b5a9-5db91928b4c5#https://echa.europa.eu/documents/10162/dca0c593-37d7-4257-9ad9-14059e525771 https://echa.europa.eu/documents/10162/fafcabed-53a7-4847-b0d6-c5243c7a6ceb https://echa.europa.eu/documents/10162/e1af509e-7b16-43bd-b0f3-d066120d55ad
Bis(pentabromophenyl) ether (decabromodiphenyl ether) (DecaBDE)
214-604-9 1163-19-5 PBT (Article 57d)#vPvB (Article 57e) 19/12/2012 https://echa.europa.eu/documents/10162/7de8998e-c87a-4fa6-82fa-927fffb0fe79 https://echa.europa.eu/documents/10162/64b5b9c4-c549-4254-a917-0ff1b7c9fa1b https://echa.europa.eu/documents/10162/b41b5e85-68c6-4522-980f-75f3e0f7f21d https://echa.europa.eu/documents/10162/c27bc8b6-ec65-47d2-b4c5-86c5b33529e9
Biphenyl-4-ylamine
202-177-1 92-67-1 Carcinogenic (Article 57a) 19/12/2012 https://echa.europa.eu/documents/10162/cefb8a85-ed61-4751-a722-2b3510d5f7a0 https://echa.europa.eu/documents/10162/22458f36-2a5f-4c1c-83b8-b8a9c45bda95 https://echa.europa.eu/documents/10162/9d518786-9c9a-4d61-b841-45ff84ed54cc https://echa.europa.eu/documents/10162/25eb6f67-afd3-4c8a-9a53-089e0811e05f
Acetic acid, lead salt, basic
257-175-3 51404-69-4 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/a68aa6d7-bc05-4f79-9445-4dd0ecabc1bb https://echa.europa.eu/documents/10162/5848ac0e-7286-4ec4-9185-49042cf54408 https://echa.europa.eu/documents/10162/e27fbdcb-b252-4912-8965-a5bb89711203 https://echa.europa.eu/documents/10162/32d7d1ed-432d-4b2d-805d-c4abf57f1fed
[Phthalato(2-)]dioxotrilead
273-688-5 69011-06-9 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/490c7cfa-ae94-48a0-83c9-99bc3c0a5e13 https://echa.europa.eu/documents/10162/430ee50c-c98e-4e96-a689-d556fdd06665 https://echa.europa.eu/documents/10162/e91058f4-7ab4-4648-91e3-3220f7ee6e8c https://echa.europa.eu/documents/10162/dc726a9a-5263-4e74-a79c-be280065cb49
6-methoxy-m-toluidine (p-cresidine)
204-419-1 120-71-8 Carcinogenic (Article 57a) 19/12/2012 https://echa.europa.eu/documents/10162/251a17a0-cc98-4151-9b3f-3526c667a90e https://echa.europa.eu/documents/10162/5c6a3acb-99f9-4561-a0a5-47b33f13c1f0 https://echa.europa.eu/documents/10162/9ee4bdb4-62a8-4ff5-a4f0-f0ced371f88f https://echa.europa.eu/documents/10162/57b50ce2-230a-4c02-8386-ab865ae627e0
4-Nonylphenol, branched and linear substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof - - Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
p-nonylphenol
203-199-4 104-40-5 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
4-(1-ethyl-1-methylhexyl)phenol
257-907-1 52427-13-1 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
4-(3,6-Dimethyl-3-heptyl)phenol
635-391-2 142731-63-3 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
4-(3,5-Dimethyl-3-heptyl)phenol
635-389-1 186825-36-5 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
Phenol, 4-nonyl-, branched
284-325-5 84852-15-3 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
p-(1,1-dimethylheptyl)phenol
250-339-5 30784-30-6 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
p-(1-methyloctyl)phenol
241-427-4 17404-66-9 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
p-isononylphenol
247-770-6 26543-97-5 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
Phenol, nonyl-, branched
291-844-0 90481-04-2 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
4-(2,6-Dimethyl-2-heptyl)phenol
635-388-6 521947-27-3 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
Nonylphenol
246-672-0 25154-52-3 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
4-(3-ethylheptan-2-yl)phenol
635-696-0 186825-39-8 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
Isononylphenol
234-284-4 11066-49-2 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/dea74d46-dc8e-4b10-947b-51a19d890153 https://echa.europa.eu/documents/10162/80751a04-fdb3-4bef-aabe-cc49da2a1148 https://echa.europa.eu/documents/10162/3024c102-20c9-4973-8f4e-7fc1dd361e7d#https://echa.europa.eu/documents/10162/19c11ec2-7e7e-4a82-935e-36c1fa13ce8d https://echa.europa.eu/documents/10162/cd32082a-e7dc-44f7-adac-18cbcf00985e
4-methyl-m-phenylenediamine (toluene-2,4-diamine)
202-453-1 95-80-7 Carcinogenic (Article 57a) 19/12/2012 https://echa.europa.eu/documents/10162/e7bb9247-f300-4887-9565-574dad453b71 https://echa.europa.eu/documents/10162/0ffceb1b-180c-4965-a526-0b2d4b73c675 https://echa.europa.eu/documents/10162/98b66e79-3f52-4792-aa74-1e9a1c674db4 https://echa.europa.eu/documents/10162/49cb5b89-169e-471d-a0b8-97dceb7ed0ee
4-aminoazobenzene
200-453-6 60-09-3 Carcinogenic (Article 57a) 19/12/2012 https://echa.europa.eu/documents/10162/9cf3cd45-97d2-455a-a58b-86d721fb4f54 https://echa.europa.eu/documents/10162/4740aca7-2e63-4f48-adf0-8c98bb12244c https://echa.europa.eu/documents/10162/bd560d2d-2ea1-4e93-950f-cca356500dbb https://echa.europa.eu/documents/10162/0062beb5-e9b8-412f-8ab3-38463705587d
4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated covering well-defined substances and UVCB substances, polymers and homologues - - Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/b823f588-7c35-4bad-9e3c-b639b627df8f https://echa.europa.eu/documents/10162/f6ae4ec7-0a73-45eb-bafb-43e37bd3b42e https://echa.europa.eu/documents/10162/c4634d14-bd48-42da-add8-dc02568bb27c https://echa.europa.eu/documents/10162/52ddc195-5dad-443b-a5e5-161b202a6a27
20-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-3,6,9,12,15,18-hexaoxaicosan-1-ol
219-682-8 2497-59-8 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/b823f588-7c35-4bad-9e3c-b639b627df8f https://echa.europa.eu/documents/10162/f6ae4ec7-0a73-45eb-bafb-43e37bd3b42e https://echa.europa.eu/documents/10162/c4634d14-bd48-42da-add8-dc02568bb27c https://echa.europa.eu/documents/10162/52ddc195-5dad-443b-a5e5-161b202a6a27
4-tert-Octylphenol monoethoxylate
621-345-9 2315-67-5 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/b823f588-7c35-4bad-9e3c-b639b627df8f https://echa.europa.eu/documents/10162/f6ae4ec7-0a73-45eb-bafb-43e37bd3b42e https://echa.europa.eu/documents/10162/c4634d14-bd48-42da-add8-dc02568bb27c https://echa.europa.eu/documents/10162/52ddc195-5dad-443b-a5e5-161b202a6a27
2-{2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy}ethanol
621-341-7 2315-61-9 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/b823f588-7c35-4bad-9e3c-b639b627df8f https://echa.europa.eu/documents/10162/f6ae4ec7-0a73-45eb-bafb-43e37bd3b42e https://echa.europa.eu/documents/10162/c4634d14-bd48-42da-add8-dc02568bb27c https://echa.europa.eu/documents/10162/52ddc195-5dad-443b-a5e5-161b202a6a27
2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethanol
618-344-0 9002-93-1 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2012 https://echa.europa.eu/documents/10162/b823f588-7c35-4bad-9e3c-b639b627df8f https://echa.europa.eu/documents/10162/f6ae4ec7-0a73-45eb-bafb-43e37bd3b42e https://echa.europa.eu/documents/10162/c4634d14-bd48-42da-add8-dc02568bb27c https://echa.europa.eu/documents/10162/52ddc195-5dad-443b-a5e5-161b202a6a27
4,4'-oxydianiline and its salts
- - Carcinogenic (Article 57a)#Mutagenic (Article 57b) 19/12/2012 https://echa.europa.eu/documents/10162/7e13f20e-aa4c-4ab9-9b57-f0bd3cf750c9 https://echa.europa.eu/documents/10162/390a50ab-4461-49fb-87da-b366f77c105b https://echa.europa.eu/documents/10162/80464fce-e4ae-4e28-b6a0-8e332daaeb95 https://echa.europa.eu/documents/10162/3c74593b-4df5-4f63-a90b-ce49a92c03f3
4,4'-oxydianiline
202-977-0 101-80-4 Carcinogenic (Article 57a)#Mutagenic (Article 57b) 19/12/2012 https://echa.europa.eu/documents/10162/7e13f20e-aa4c-4ab9-9b57-f0bd3cf750c9 https://echa.europa.eu/documents/10162/390a50ab-4461-49fb-87da-b366f77c105b https://echa.europa.eu/documents/10162/80464fce-e4ae-4e28-b6a0-8e332daaeb95 https://echa.europa.eu/documents/10162/3c74593b-4df5-4f63-a90b-ce49a92c03f3
4,4'-methylenedi-o-toluidine
212-658-8 838-88-0 Carcinogenic (Article 57a) 19/12/2012 https://echa.europa.eu/documents/10162/aa8680a2-aecb-4b86-b4e9-e6d6ba41ed42 https://echa.europa.eu/documents/10162/7fabc585-9a8c-4105-99ad-4083a41b2310 https://echa.europa.eu/documents/10162/42094854-61af-4a51-abc4-0f85ef9bd51e https://echa.europa.eu/documents/10162/b9f50e05-2707-4623-83a4-18c2284d301b
3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine
421-150-7 143860-04-2 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/2e6fa094-c665-4367-b4d6-d61b841e82c3 https://echa.europa.eu/documents/10162/c2ba8775-69b2-4dbe-b725-54e8219f10ae https://echa.europa.eu/documents/10162/782e61c7-07e8-42be-bfb7-99c2bdab913a https://echa.europa.eu/documents/10162/da9c0934-4356-4188-9ae1-6d4da2c5d4a0
1-bromopropane (n-propyl bromide)
203-445-0 106-94-5 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/322977d5-5c50-467b-a5aa-14dd621301af https://echa.europa.eu/documents/10162/0fde3877-5c84-4343-ad20-a3327752a13a https://echa.europa.eu/documents/10162/d28691f1-5df6-47a4-97ae-4383e7aa637e https://echa.europa.eu/documents/10162/59737f9b-00db-4ca7-acb5-2b8e4733a073
1,2-diethoxyethane
211-076-1 629-14-1 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/c5d3b97f-9168-4c49-aa69-9197cd899a8d https://echa.europa.eu/documents/10162/8393ce5a-9456-4abb-b6ba-008e68941823 https://echa.europa.eu/documents/10162/8c04401d-d0bb-409c-9250-c6e574f47305 https://echa.europa.eu/documents/10162/d8f69d16-1114-4322-976c-1c3779cf9344
1,2-Benzenedicarboxylic acid, dipentyl ester, branched and linear
284-032-2 84777-06-0 Toxic for reproduction (Article 57c) 19/12/2012 https://echa.europa.eu/documents/10162/cdf66098-5920-44ea-9d26-aaa390c5d5ef https://echa.europa.eu/documents/10162/6f9bf9c8-8442-48fe-b38e-4dca50adea4c https://echa.europa.eu/documents/10162/329c8367-0ec9-426b-bcfe-27ddf27fb777 https://echa.europa.eu/documents/10162/dd93a052-4733-4115-84de-34f9c0dda535
α,α-Bis[4-(dimethylamino)phenyl]-4 (phenylamino)naphthalene-1-methanol (C.I. Solvent Blue 4) with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2) 229-851-8 6786-83-0 Carcinogenic (Article 57a) 18/06/2012 https://echa.europa.eu/documents/10162/6ea9ffc1-a165-4afc-b504-af2bc3694c64 https://echa.europa.eu/documents/10162/09c5c1e5-3d1f-4c79-8d8a-f142e7dc42ab https://echa.europa.eu/documents/10162/d3bc3564-1f27-4b6b-b076-695ee0a3ad10 https://echa.europa.eu/documents/10162/46b2438a-b97d-4faa-90f7-3395c3d64530
N,N,N',N'-tetramethyl-4,4'-methylenedianiline (Michler’s base)
202-959-2 101-61-1 Carcinogenic (Article 57a) 18/06/2012 https://echa.europa.eu/documents/10162/55c7a0fd-13f8-41bd-b1b2-123cdeef4434 https://echa.europa.eu/documents/10162/bb71dff3-cbb8-42e4-8d18-529e5876b710 https://echa.europa.eu/documents/10162/14f93f87-28aa-4295-a2a6-6b18e53abbf2 https://echa.europa.eu/documents/10162/62ef285f-3e65-44e1-b898-a8ae3401839b
Lead(II) bis(methanesulfonate) - 401-750-5 17570-76-2 Toxic for reproduction (Article 57c) 18/06/2012 https://echa.europa.eu/documents/10162/670a5290-68d3-4b88-83e8-6c06a4e430a8 https://echa.europa.eu/documents/10162/71993287-68f1-43c4-a13e-326ad171b80c https://echa.europa.eu/documents/10162/ec18fb5f-b968-4e34-a146-e696fccad746 https://echa.europa.eu/documents/10162/6e530a22-8733-4130-83e2-0722b5632d48
Formamide
200-842-0 75-12-7 Toxic for reproduction (Article 57c) 18/06/2012 https://echa.europa.eu/documents/10162/64c72b55-a1da-47ef-b47d-edad9c9f124e https://echa.europa.eu/documents/10162/a330365d-7a44-43a1-a896-0fec7f34c4e6 https://echa.europa.eu/documents/10162/4ff18575-7bcc-4e02-96db-1090a1bdd3a1 https://echa.europa.eu/documents/10162/05287d61-9686-4368-bb18-39e6b62755bb
Diboron trioxide
215-125-8 1303-86-2 Toxic for reproduction (Article 57c) 18/06/2012 https://echa.europa.eu/documents/10162/c42c7cd8-b8d9-4a53-987e-55f8b377ea03 https://echa.europa.eu/documents/10162/de509422-112a-4234-8e67-3260d2051364 https://echa.europa.eu/documents/10162/6b35228c-45c4-4ed8-88b0-823fafb0d795 https://echa.europa.eu/documents/10162/f6c7ef7e-c40f-4ecc-b898-5af124b6156d
[4-[[4-anilino-1-naphthyl][4-(dimethylamino)phenyl]methylene]cyclohexa-2,5-dien-1-ylidene] dimethylammonium chloride (C.I. Basic Blue 26) with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2) 219-943-6 2580-56-5 Carcinogenic (Article 57a) 18/06/2012 https://echa.europa.eu/documents/10162/4575515a-f67b-447e-afb0-9de9bdf2d8b4 https://echa.europa.eu/documents/10162/e788094b-c091-40fc-af06-0cb993da22ef https://echa.europa.eu/documents/10162/4005564c-2ff2-4ea5-941d-04525939d70b https://echa.europa.eu/documents/10162/04a4c5fd-4f23-42c0-9ac5-5a246d2fe196
[4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride (C.I. Basic Violet 3) with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2) 208-953-6 548-62-9 Carcinogenic (Article 57a) 18/06/2012 https://echa.europa.eu/documents/10162/9c2106dd-ab9a-415d-8b47-039c5b5b223a https://echa.europa.eu/documents/10162/2b47d136-adc9-46de-88c8-4ac990880005 https://echa.europa.eu/documents/10162/a3290dc9-a3e1-4a9d-8e58-102dca785d19 https://echa.europa.eu/documents/10162/526a2f25-b203-479b-ade6-270a2fa47f8a
4,4'-bis(dimethylamino)benzophenone (Michler’s ketone)
202-027-5 90-94-8 Carcinogenic (Article 57a) 18/06/2012 https://echa.europa.eu/documents/10162/fb031b0c-5e13-438a-a0ad-334a822c2e04 https://echa.europa.eu/documents/10162/a32d3dd2-1045-457b-9a6b-988bc641e662 https://echa.europa.eu/documents/10162/3cbcf0fc-f6bc-4d08-8dcf-b2837657e1c5 https://echa.europa.eu/documents/10162/407ab3cf-561a-48b9-a8e8-109670a31021
4,4'-bis(dimethylamino)-4''-(methylamino)trityl alcohol with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2) 209-218-2 561-41-1 Carcinogenic (Article 57a) 18/06/2012 https://echa.europa.eu/documents/10162/bcf29e5e-c152-4f88-8df9-1f9515582e3e https://echa.europa.eu/documents/10162/0bc3c72f-1e50-45e7-98c4-595639fe3010 https://echa.europa.eu/documents/10162/4300b1a0-79ae-4d90-bcac-07a34691c435 https://echa.europa.eu/documents/10162/cff120ad-ba8c-4324-a00a-0447570b6032
1,3,5-tris[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione (β-TGIC) - 423-400-0 59653-74-6 Mutagenic (Article 57b) 18/06/2012 https://echa.europa.eu/documents/10162/b396da4a-879d-4d97-88c0-f2a97c3160e2 https://echa.europa.eu/documents/10162/1b1db3da-9d3c-4dd9-aec6-82e5f2bb9681 https://echa.europa.eu/documents/10162/9c7289c0-b92d-46cb-9007-6a919f003935 https://echa.europa.eu/documents/10162/2ae516e0-2d83-437d-b195-4accb6ac3dc3
1,3,5-Tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione (TGIC)
219-514-3 2451-62-9 Mutagenic (Article 57b) 18/06/2012 https://echa.europa.eu/documents/10162/f4f2cac7-9277-4dd0-bcfc-a0b3134331a3 https://echa.europa.eu/documents/10162/5e64cc7a-5599-48af-86ea-4cd5d853cb9a https://echa.europa.eu/documents/10162/b0f7fcea-3dd5-4281-ab06-fd46c48d2ec2 https://echa.europa.eu/documents/10162/a9f8bf58-a02b-4f0b-8685-3bef8b09e73a
1,2-bis(2-methoxyethoxy)ethane (TEGDME; triglyme)
203-977-3 112-49-2 Toxic for reproduction (Article 57c) 18/06/2012 https://echa.europa.eu/documents/10162/1797f7da-12f2-4db5-95ee-d8b2f119255b https://echa.europa.eu/documents/10162/077454da-571b-43dd-98c6-ce04427310e9 https://echa.europa.eu/documents/10162/04a4b3ea-09d6-439a-bf05-079784355127 https://echa.europa.eu/documents/10162/1a3f3c1d-61e0-42e7-ae85-f2f4a1a0ec59
1, 2-dimethoxyethane; ethylene glycol dimethyl ether (EGDME)
203-794-9 110-71-4 Toxic for reproduction (Article 57c) 18/06/2012 https://echa.europa.eu/documents/10162/8baf4265-833f-467d-bb3d-cf3dfe92be88 https://echa.europa.eu/documents/10162/964d2219-db3d-4fd4-8fb4-5264b7cea5ab https://echa.europa.eu/documents/10162/466dce51-6adf-4936-874b-2c1fe8c9de5e https://echa.europa.eu/documents/10162/2a690d97-dd42-4a70-9f48-478eff22cfb2
Zirconia Aluminosilicate Refractory Ceramic Fibres are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium, silicon and zirconium are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm). c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight - - Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/0d43d978-af14-4acf-9613-95d028fef958#https://echa.europa.eu/documents/10162/46da04ed-c0ac-482e-aa63-c75553312e84 https://echa.europa.eu/documents/10162/a9f47855-ffbe-4312-84f9-8d74aa409f00 https://echa.europa.eu/documents/10162/8190e8e4-e315-4bcb-91f5-1548fbe46bc1 https://echa.europa.eu/documents/10162/dd8384e5-5528-4828-b6f4-a78239f11254
Trilead diarsenate
222-979-5 3687-31-8 Carcinogenic (Article 57a)#Toxic for reproduction (Article 57c) 19/12/2011 https://echa.europa.eu/documents/10162/f94e0b50-062a-4150-8652-f5d3ac218fcd https://echa.europa.eu/documents/10162/18ce9105-2407-45b5-852b-5329e6042900 https://echa.europa.eu/documents/10162/69699398-ddf0-4188-988f-a2464175a019 https://echa.europa.eu/documents/10162/359202d6-7c80-41af-b982-49ccd82c376c
Potassium hydroxyoctaoxodizincatedichromate
234-329-8 11103-86-9 Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/cbc1bcf1-2910-4813-a818-9f2069f69b3c https://echa.europa.eu/documents/10162/2869cfe1-049b-43b2-a1b0-c8503d2c2586 https://echa.europa.eu/documents/10162/fb533ed0-2765-4ad3-acf7-79d9ca8a5b02 https://echa.europa.eu/documents/10162/77361790-57fb-466d-ba94-57c264d8f650
Phenolphthalein
201-004-7 77-09-8 Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/37893eb4-a79b-4982-a3f0-34438dc72904 https://echa.europa.eu/documents/10162/2cc034c5-ecbf-4c6c-8de4-9085c3e4f2a0 https://echa.europa.eu/documents/10162/1f29b212-4a70-40c0-94de-8dfce7791aa9 https://echa.europa.eu/documents/10162/7a85a321-9cbe-4abc-951a-ef0c8ba6bc9c
Pentazinc chromate octahydroxide
256-418-0 49663-84-5 Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/756bf74c-275b-4779-8d92-83fc3ac27318 https://echa.europa.eu/documents/10162/3acce581-104b-4f80-8b0b-94728b9d501c https://echa.europa.eu/documents/10162/ce28c0be-379f-461e-9197-3af36d5c7f53 https://echa.europa.eu/documents/10162/e7b5e2f6-8c30-4909-8945-0626f4bdc247
N,N-dimethylacetamide
204-826-4 127-19-5 Toxic for reproduction (Article 57c) 19/12/2011 https://echa.europa.eu/documents/10162/65231f68-fe7a-4712-9f3a-99a9fdfb7dea https://echa.europa.eu/documents/10162/f3d28fdc-113a-454a-9de2-e5fa2bb7786d https://echa.europa.eu/documents/10162/42751bc8-cad5-4035-82ea-a91c0efe5768 https://echa.europa.eu/documents/10162/45e71828-20d1-498a-9872-aec6010fdba2
Lead styphnate
239-290-0 15245-44-0 Toxic for reproduction (Article 57c) 19/12/2011 https://echa.europa.eu/documents/10162/9f6e771e-a50c-4079-9a1a-1d2441ed0033 https://echa.europa.eu/documents/10162/940e8b74-d5c3-446e-a041-b86297a880c6 https://echa.europa.eu/documents/10162/fbb1d8a9-4e09-4c36-8e79-c46f9a73bb7c https://echa.europa.eu/documents/10162/934096e2-d46a-4ad9-b0d0-be85915fdf65
Lead dipicrate
229-335-2 6477-64-1 Toxic for reproduction (Article 57c) 19/12/2011 https://echa.europa.eu/documents/10162/3a01a0ae-69e4-4b0c-8d87-e5c42e8586a3 https://echa.europa.eu/documents/10162/0a46d3e7-e3be-46bc-886b-d04e944ad448 https://echa.europa.eu/documents/10162/8a7c6915-0578-4c50-8fea-5208e237e0a7 https://echa.europa.eu/documents/10162/e5b911c5-e2ba-482b-a579-4e21ae450d59
Lead diazide, Lead azide
236-542-1 13424-46-9 Toxic for reproduction (Article 57c) 19/12/2011 https://echa.europa.eu/documents/10162/defeb72b-e314-4707-b01d-dd25464eb5f1 https://echa.europa.eu/documents/10162/cacccb51-ab67-4ee5-803f-f147d01feddc https://echa.europa.eu/documents/10162/9890a34b-0a57-4286-a2ab-b226ba3dfef3 https://echa.europa.eu/documents/10162/adc57b82-3653-4997-9c44-a9430e455cc7
Formaldehyde, oligomeric reaction products with aniline
500-036-1 25214-70-4 Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/f5ad72aa-57b0-456b-acca-080ea744a5d1 https://echa.europa.eu/documents/10162/3ccc2258-f2d9-4330-b218-b781178c00a2 https://echa.europa.eu/documents/10162/9cd084c9-8c83-4cf4-81c9-f43d5c1f1fe8 https://echa.europa.eu/documents/10162/feb90681-3d07-4b5b-b85d-749dd458d145
Dichromium tris(chromate)
246-356-2 24613-89-6 Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/b5600741-d5d7-413c-9755-625a596d1ee1 https://echa.europa.eu/documents/10162/3d86d90e-9593-4987-9856-639068f57402 https://echa.europa.eu/documents/10162/6426d317-2c05-40ba-90ae-0fbd67774f53 https://echa.europa.eu/documents/10162/d77befb5-04ac-417d-9032-4fc727ddce33
Calcium arsenate
231-904-5 7778-44-1 Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/cb4e87e7-ebdc-4a02-8333-7b30084a9be4 https://echa.europa.eu/documents/10162/00c3ba78-f33e-461f-9fdd-4c365f2b5b23 https://echa.europa.eu/documents/10162/ccc629ba-7feb-462d-bce8-86ac200de8f5 https://echa.europa.eu/documents/10162/d0db9dbb-b12e-4da2-a217-b6cd0d306f6a
Bis(2-methoxyethyl) phthalate
204-212-6 117-82-8 Toxic for reproduction (Article 57c) 19/12/2011 https://echa.europa.eu/documents/10162/18fc6f65-fb18-4151-b737-45ba0aefb181 https://echa.europa.eu/documents/10162/5d0a79ed-4557-4a6c-8017-fda04a4eb326 https://echa.europa.eu/documents/10162/bee2930b-03bb-4293-bda1-89381f8da2a6 https://echa.europa.eu/documents/10162/aae6e8e0-190c-42b9-aab9-55975c427bab
Bis(2-methoxyethyl) ether
203-924-4 111-96-6 Toxic for reproduction (Article 57c) 19/12/2011 https://echa.europa.eu/documents/10162/ee023359-daa8-43a2-8c82-242f0a7588f7 https://echa.europa.eu/documents/10162/169db6b2-a42d-46f3-8daf-a7d8385e84b4 https://echa.europa.eu/documents/10162/2e6c10fa-03d5-47b2-9337-e047743554b9 https://echa.europa.eu/documents/10162/8e589331-519c-4502-a246-19c150dc9bca
Arsenic acid
231-901-9 7778-39-4 Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/3646fac6-947b-41ea-b3bf-e231511be65c https://echa.europa.eu/documents/10162/c61d2694-b4f4-41c0-93da-68e959341b9c https://echa.europa.eu/documents/10162/bc77d03b-2f02-4084-8fab-2b8d586f342a https://echa.europa.eu/documents/10162/bfa38ed0-d163-488a-a5d0-27c420eb04be
Aluminosilicate Refractory Ceramic Fibres are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium and silicon are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm) c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight - - Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/df7f314c-bda4-496c-8d86-04fe2421e157#https://echa.europa.eu/documents/10162/9c0854f5-3f46-4dc5-9776-72ac20f908e2 https://echa.europa.eu/documents/10162/71a6c340-4c9c-41d9-8c26-6e8d3236e456 https://echa.europa.eu/documents/10162/611cb779-7564-4a89-b381-c5a126b5a04b https://echa.europa.eu/documents/10162/62c80aaa-af09-448d-8f23-4bd43742db6b
4-(1,1,3,3-tetramethylbutyl)phenol
205-426-2 140-66-9 Endocrine disrupting properties (Article 57(f) - environment) 19/12/2011 https://echa.europa.eu/documents/10162/189c55b4-d54b-4271-9e50-ce798faf9f4c https://echa.europa.eu/documents/10162/4c196bd6-2a91-4cb1-82ae-c65cb8a637ac https://echa.europa.eu/documents/10162/4c6cccfd-d366-4a00-87e5-65aa77181fb6 https://echa.europa.eu/documents/10162/269c74a0-d34d-4493-8caa-f6ecec868f90
2-Methoxyaniline, o-Anisidine
201-963-1 90-04-0 Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/30d99b89-85a5-45d1-8701-1ad0680afb1e https://echa.europa.eu/documents/10162/80f2ea14-b438-4ae6-bbcd-b6b214c7ae04 https://echa.europa.eu/documents/10162/faf9ec9a-af59-4c1d-b944-cc831b3b52b3 https://echa.europa.eu/documents/10162/8172e9b4-659b-4027-8ae0-0ec8dd5d5f7e
2,2'-dichloro-4,4'-methylenedianiline
202-918-9 101-14-4 Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/0a89c9f0-1da4-406b-8285-9db907cdb66a https://echa.europa.eu/documents/10162/40909414-f320-4c4d-8519-3b9895c794e1 https://echa.europa.eu/documents/10162/6f0cee92-fe4f-492d-b8e1-78ac46ee1a85 https://echa.europa.eu/documents/10162/f32433f8-4c7b-4fe4-8601-a6ae79de51d9
1,2-dichloroethane
203-458-1 107-06-2 Carcinogenic (Article 57a) 19/12/2011 https://echa.europa.eu/documents/10162/55390ac1-1267-4141-af33-67c787b50a0d https://echa.europa.eu/documents/10162/9e0c9155-9ec9-489a-976d-4312ab5838cf https://echa.europa.eu/documents/10162/a40ec08f-918f-4f60-b1f4-43a9517f6433 https://echa.europa.eu/documents/10162/84c20016-56a8-422b-b4b8-cd664b1ad191
Strontium chromate
232-142-6 7789-06-2 Carcinogenic (Article 57a) 20/06/2011 https://echa.europa.eu/documents/10162/8003d372-68f9-4a5a-9094-4e6d0b58169c https://echa.europa.eu/documents/10162/dbf5f0a3-13f7-4dcc-9638-be11aa9796bc https://echa.europa.eu/documents/10162/b404f6d6-e6a2-412a-8362-542d297fd1bd https://echa.europa.eu/documents/10162/3b778214-51a1-44f1-9109-864228f64111
Hydrazine
206-114-9 302-01-2, 7803-57-8 Carcinogenic (Article 57a) 20/06/2011 https://echa.europa.eu/documents/10162/c5b972a9-f57f-4fd5-8177-04b4e46c5e93 https://echa.europa.eu/documents/10162/8c489ab1-cc43-4655-9fdf-9ba8faffec98 https://echa.europa.eu/documents/10162/dcbad586-92e2-496c-bf17-f2d4fd7a7e5e https://echa.europa.eu/documents/10162/bd2d041f-e43c-4952-a9d0-00c3e0c32817
2-ethoxyethyl acetate
203-839-2 111-15-9 Toxic for reproduction (Article 57c) 20/06/2011 https://echa.europa.eu/documents/10162/4b69d66f-b3f9-4b3d-a1fb-a90c4825f7d5 https://echa.europa.eu/documents/10162/a4d1618e-1de0-45ee-95d4-7c0b97f8f4bb https://echa.europa.eu/documents/10162/e3566164-121d-4007-9f6c-eeb1bbe67c14 https://echa.europa.eu/documents/10162/d7830695-b04b-413a-93ed-c4e2ccb9320b
1-Methyl-2-pyrrolidone (NMP)
212-828-1 872-50-4 Toxic for reproduction (Article 57c) 20/06/2011 https://echa.europa.eu/documents/10162/2d6cdfd7-e924-45fa-85d4-4450a7b4bf5a https://echa.europa.eu/documents/10162/2a739583-e50d-458f-860b-2170d391621d https://echa.europa.eu/documents/10162/1c4e3474-34ee-4c15-aaef-dafd1cb47779 https://echa.europa.eu/documents/10162/43a7d148-39d0-40d9-8fec-87c33877890e
1,2-Benzenedicarboxylic acid, di-C7-11-branched and linear alkyl esters
271-084-6 68515-42-4 Toxic for reproduction (Article 57c) 20/06/2011 https://echa.europa.eu/documents/10162/e0602e69-f758-4eef-88c6-6e9c7a0359e6 https://echa.europa.eu/documents/10162/607fe319-a2a5-412f-9411-7fe86a8dd261 https://echa.europa.eu/documents/10162/9064c470-918c-4459-b1de-f6112da0a8ec https://echa.europa.eu/documents/10162/faa636cc-eb12-4f43-a470-ee9eeb4bcf81
1,2-Benzenedicarboxylic acid, di-C6-8-branched alkyl esters, C7-rich
276-158-1 71888-89-6 Toxic for reproduction (Article 57c) 20/06/2011 https://echa.europa.eu/documents/10162/1d278ff8-5bc6-4fa4-8b6a-6847121fcc9d https://echa.europa.eu/documents/10162/23661523-674a-4366-bf5d-8597e97f09a5 https://echa.europa.eu/documents/10162/4ecec0c5-de0a-403e-8bad-bb2439aed1cd https://echa.europa.eu/documents/10162/0afc08b5-d558-4525-847a-3a1d9b156ac6
1,2,3-trichloropropane
202-486-1 96-18-4 Carcinogenic (Article 57a)#Toxic for reproduction (Article 57c) 20/06/2011 https://echa.europa.eu/documents/10162/6b5d8cc7-e37e-46e1-9d91-0f8d529ca833 https://echa.europa.eu/documents/10162/5c763e23-3df9-4568-990f-df7d38977711 https://echa.europa.eu/documents/10162/e8d4bcbd-81c1-4a59-a97d-d1cb30c29ec8 https://echa.europa.eu/documents/10162/05d2da5c-e325-40f8-a2b2-22869c630070
Cobalt(II) sulphate
233-334-2 10124-43-3 Carcinogenic (Article 57a)#Toxic for reproduction (Article 57c) 15/12/2010 https://echa.europa.eu/documents/10162/034150e5-fa99-4659-a208-3492fed19012 https://echa.europa.eu/documents/10162/6156179b-31de-4d5a-8bde-4c596e132251 https://echa.europa.eu/documents/10162/5fa87d07-2872-4502-b07c-4186797aa442 https://echa.europa.eu/documents/10162/e34d0158-3280-470f-aff4-915959abe1d2
Cobalt(II) dinitrate
233-402-1 10141-05-6 Carcinogenic (Article 57a)#Toxic for reproduction (Article 57c) 15/12/2010 https://echa.europa.eu/documents/10162/93d2146d-6f41-43f1-9e4c-6c65ee52bfee https://echa.europa.eu/documents/10162/b0db8920-3429-46d7-9788-9f327712301d https://echa.europa.eu/documents/10162/a6ff4bdb-6aa3-48ff-b9b4-6f086d8f35fa https://echa.europa.eu/documents/10162/592637d9-a280-4d3b-852c-6bbd66ed3965
Cobalt(II) diacetate
200-755-8 71-48-7 Carcinogenic (Article 57a)#Toxic for reproduction (Article 57c) 15/12/2010 https://echa.europa.eu/documents/10162/454374bb-5c3a-4716-bce2-2bf2879536d3 https://echa.europa.eu/documents/10162/b7623ce3-4a1d-4b72-8bd3-b40872dde269 https://echa.europa.eu/documents/10162/f68e76b3-751d-48b4-a225-4a23c0ee6249 https://echa.europa.eu/documents/10162/25ff55c6-3f80-47f1-a40c-b8da3bc45a23
Cobalt(II) carbonate
208-169-4 513-79-1 Carcinogenic (Article 57a)#Toxic for reproduction (Article 57c) 15/12/2010 https://echa.europa.eu/documents/10162/75006cd4-1dc6-47de-bc84-dd92e07201a9 https://echa.europa.eu/documents/10162/8724ec6d-5db0-4768-a9a9-43174499cde5 https://echa.europa.eu/documents/10162/efdc02e9-f1e6-47c7-872b-7d6285457495 https://echa.europa.eu/documents/10162/55e40495-4f8f-443b-8658-04e2622cc4f3
Chromium trioxide
215-607-8 1333-82-0 Carcinogenic (Article 57a)#Mutagenic (Article 57b) 15/12/2010 https://echa.europa.eu/documents/10162/6b11ec66-9d90-400a-a61a-90de9a0fd8b1 https://echa.europa.eu/documents/10162/26e69088-ff48-41b2-86be-ad93559d4c1d https://echa.europa.eu/documents/10162/6b7798d0-6e23-4e72-a1ea-ec989ef1e9b6 https://echa.europa.eu/documents/10162/63996442-9c58-44ba-8d4a-d94456e5f762
Acids generated from chromium trioxide and their oligomers
- - Carcinogenic (Article 57a) 15/12/2010 https://echa.europa.eu/documents/10162/7ec3a9eb-a9f6-4e82-9e7d-99794b3dc95e https://echa.europa.eu/documents/10162/e49af511-8109-4671-87c9-d1929bd1f9df#https://echa.europa.eu/documents/10162/b3342013-b216-403f-b9f6-ea2d704d45e3 https://echa.europa.eu/documents/10162/b4e7126f-3045-4159-8142-958061cf13ac https://echa.europa.eu/documents/10162/7e1247f2-9a4a-44a6-b267-532665d9bbff
Chromic acid
231-801-5 7738-94-5 Carcinogenic (Article 57a) 15/12/2010 https://echa.europa.eu/documents/10162/7ec3a9eb-a9f6-4e82-9e7d-99794b3dc95e https://echa.europa.eu/documents/10162/e49af511-8109-4671-87c9-d1929bd1f9df#https://echa.europa.eu/documents/10162/b3342013-b216-403f-b9f6-ea2d704d45e3 https://echa.europa.eu/documents/10162/b4e7126f-3045-4159-8142-958061cf13ac https://echa.europa.eu/documents/10162/7e1247f2-9a4a-44a6-b267-532665d9bbff
Oligomers of chromic acid and dichromic acid
- - Carcinogenic (Article 57a) 15/12/2010 https://echa.europa.eu/documents/10162/7ec3a9eb-a9f6-4e82-9e7d-99794b3dc95e https://echa.europa.eu/documents/10162/e49af511-8109-4671-87c9-d1929bd1f9df#https://echa.europa.eu/documents/10162/b3342013-b216-403f-b9f6-ea2d704d45e3 https://echa.europa.eu/documents/10162/b4e7126f-3045-4159-8142-958061cf13ac https://echa.europa.eu/documents/10162/7e1247f2-9a4a-44a6-b267-532665d9bbff
Dichromic acid
236-881-5 13530-68-2 Carcinogenic (Article 57a) 15/12/2010 https://echa.europa.eu/documents/10162/7ec3a9eb-a9f6-4e82-9e7d-99794b3dc95e https://echa.europa.eu/documents/10162/e49af511-8109-4671-87c9-d1929bd1f9df#https://echa.europa.eu/documents/10162/b3342013-b216-403f-b9f6-ea2d704d45e3 https://echa.europa.eu/documents/10162/b4e7126f-3045-4159-8142-958061cf13ac https://echa.europa.eu/documents/10162/7e1247f2-9a4a-44a6-b267-532665d9bbff
2-methoxyethanol
203-713-7 109-86-4 Toxic for reproduction (Article 57c) 15/12/2010 https://echa.europa.eu/documents/10162/d0434782-81cb-43af-ba42-88c301aeb105 https://echa.europa.eu/documents/10162/2c32ce81-9fe4-4bec-ab99-cefb0db64f70 https://echa.europa.eu/documents/10162/de7fb120-e51b-408c-9753-5c605be53de9 https://echa.europa.eu/documents/10162/8d11abdf-9416-4f6f-9bd2-19292333cb3c
2-ethoxyethanol
203-804-1 110-80-5 Toxic for reproduction (Article 57c) 15/12/2010 https://echa.europa.eu/documents/10162/f25b7ab7-c339-4b4a-900b-7a2d38c32c1f https://echa.europa.eu/documents/10162/16b140dd-f4a7-4b4c-a7c4-696ff16785ea https://echa.europa.eu/documents/10162/b8b0b5ed-43be-4c24-8d81-96b799916955 https://echa.europa.eu/documents/10162/442eecec-84a6-49eb-b758-1e6eaedfae06
Trichloroethylene
201-167-4 79-01-6 Carcinogenic (Article 57a) 18/06/2010 https://echa.europa.eu/documents/10162/d54e4381-eebe-41dd-9eb5-5794d383f043 https://echa.europa.eu/documents/10162/bf5436ce-44ed-49c8-b7e6-51804d3cb0a5 https://echa.europa.eu/documents/10162/8bbf5e70-f0a4-46c0-84db-f2340c74d64e https://echa.europa.eu/documents/10162/b7a78996-abe6-42bf-87f8-9d233aa19da6
Tetraboron disodium heptaoxide, hydrate
235-541-3 12267-73-1 Toxic for reproduction (Article 57c) 18/06/2010 https://echa.europa.eu/documents/10162/4ed94bb5-533a-4a8a-823f-6348859263d1 https://echa.europa.eu/documents/10162/b743c746-3dd3-4ddb-83f9-8446d5615222 https://echa.europa.eu/documents/10162/a049f842-ad66-4b06-b1ec-39fd6c6f47ba https://echa.europa.eu/documents/10162/6d2ff32f-1fb8-4936-81ed-83b690e8128f
Sodium chromate
231-889-5 7775-11-3 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#Toxic for reproduction (Article 57c) 18/06/2010 https://echa.europa.eu/documents/10162/f7a917fb-3073-4f18-93db-d49e3587df84 https://echa.europa.eu/documents/10162/604acc0d-b03f-4c88-b9e1-574a0709b463 https://echa.europa.eu/documents/10162/c5d6f8de-bbe1-4b31-b7c4-d8e5b8d65517 https://echa.europa.eu/documents/10162/28dc06fd-f76c-4687-9444-03f22cc7ed54
Potassium dichromate
231-906-6 7778-50-9 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#Toxic for reproduction (Article 57c) 18/06/2010 https://echa.europa.eu/documents/10162/0f342468-8b83-48af-b1ce-c46eb9e011bf https://echa.europa.eu/documents/10162/cb89dff1-a881-4c96-98aa-058ddaf85532 https://echa.europa.eu/documents/10162/3ac167c4-9f8e-4375-92f6-285a2911cee0 https://echa.europa.eu/documents/10162/de24ba90-4d84-42c3-adf7-f4e8f0f8a67d
Potassium chromate
232-140-5 7789-00-6 Carcinogenic (Article 57a)#Mutagenic (Article 57b) 18/06/2010 https://echa.europa.eu/documents/10162/4116dc63-d4ff-4465-b598-a81622c5f58b https://echa.europa.eu/documents/10162/6ca9ac30-7102-4c5a-9eb8-bbcefc64c411 https://echa.europa.eu/documents/10162/e6da86f5-0988-4fb2-9dcf-84087571c5af https://echa.europa.eu/documents/10162/8df07972-8668-47d4-a32f-0583f64820a7
Disodium tetraborate, anhydrous
215-540-4 12179-04-3, 1303-96-4, 1330-43-4 Toxic for reproduction (Article 57c) 18/06/2010 https://echa.europa.eu/documents/10162/4912ba63-c1c1-4698-b1a0-3b58f6024cd5 https://echa.europa.eu/documents/10162/423223b2-23c6-4203-a1c5-c1e4cf47e854 https://echa.europa.eu/documents/10162/04e29ef1-f56d-4926-96f6-c2865c5e10a7 https://echa.europa.eu/documents/10162/9004f5d0-c545-42ce-8839-e07b8f938e7a
Boric acid EC No. 233-139-2 and EC No. 234-343-4 - - Toxic for reproduction (Article 57c) 18/06/2010 https://echa.europa.eu/documents/10162/6877f24b-c82b-4021-b05b-a25af94185c0 https://echa.europa.eu/documents/10162/cad21145-7d6a-4c1f-b640-80cfe475b45c#https://echa.europa.eu/documents/10162/910d71c0-785a-4b54-997a-6b4396389739 https://echa.europa.eu/documents/10162/d51fd473-40ec-4831-bc2d-6f53bdf9cbbe https://echa.europa.eu/documents/10162/324a7df5-597a-42e5-8f9f-c10f978a94fa
Boric acid, crude natural
234-343-4 11113-50-1 Toxic for reproduction (Article 57c) 18/06/2010 https://echa.europa.eu/documents/10162/6877f24b-c82b-4021-b05b-a25af94185c0 https://echa.europa.eu/documents/10162/cad21145-7d6a-4c1f-b640-80cfe475b45c#https://echa.europa.eu/documents/10162/910d71c0-785a-4b54-997a-6b4396389739 https://echa.europa.eu/documents/10162/d51fd473-40ec-4831-bc2d-6f53bdf9cbbe https://echa.europa.eu/documents/10162/324a7df5-597a-42e5-8f9f-c10f978a94fa
Boric acid
233-139-2 10043-35-3 Toxic for reproduction (Article 57c) 18/06/2010 https://echa.europa.eu/documents/10162/6877f24b-c82b-4021-b05b-a25af94185c0 https://echa.europa.eu/documents/10162/cad21145-7d6a-4c1f-b640-80cfe475b45c#https://echa.europa.eu/documents/10162/910d71c0-785a-4b54-997a-6b4396389739 https://echa.europa.eu/documents/10162/d51fd473-40ec-4831-bc2d-6f53bdf9cbbe https://echa.europa.eu/documents/10162/324a7df5-597a-42e5-8f9f-c10f978a94fa
Ammonium dichromate
232-143-1 7789-09-5 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#Toxic for reproduction (Article 57c) 18/06/2010 https://echa.europa.eu/documents/10162/ff5cd363-1d18-4b42-a208-b0aa4034348e https://echa.europa.eu/documents/10162/e3fb1a7c-4bd5-4540-9997-fc9f040c1a2f https://echa.europa.eu/documents/10162/b09ce051-1fe5-425a-bdd0-0f6eb628230b https://echa.europa.eu/documents/10162/318f7c0e-5c2c-4ba9-a2c4-7f8f3335b75f
Acrylamide
201-173-7 79-06-1 Carcinogenic (Article 57a)#Mutagenic (Article 57b) 30/03/2010 https://echa.europa.eu/documents/10162/b280c0f2-f957-44d9-9584-097444464b22 https://echa.europa.eu/documents/10162/13141b6e-f285-44bf-9868-d5e089875101 https://echa.europa.eu/documents/10162/7f1a698d-9910-4e8a-a6a7-0806427abd26 https://echa.europa.eu/documents/10162/98bfa10b-2c8c-4bb4-914b-88f68b9bc955
Tris(2-chloroethyl) phosphate
204-118-5 115-96-8 Toxic for reproduction (Article 57c) 13/01/2010 https://echa.europa.eu/documents/10162/78d8ecfd-5e83-4299-9f16-15681ee11bbb https://echa.europa.eu/documents/10162/d36f5718-6e5c-4fca-9e31-efed9c50d0d0 https://echa.europa.eu/documents/10162/6d09755f-7fcb-4a00-b7ce-91ab45a2e5af https://echa.europa.eu/documents/10162/8d912dea-4ebb-44f7-8fa7-eac5caf764c9
Pitch, coal tar, high-temp. - 266-028-2 65996-93-2 Carcinogenic (Article 57a)#PBT (Article 57d)#vPvB (Article 57e) 13/01/2010 https://echa.europa.eu/documents/10162/30488018-7d14-42b1-90eb-8235974bf023 https://echa.europa.eu/documents/10162/d3d19672-64d5-47f4-aa47-66729f6990ec https://echa.europa.eu/documents/10162/73d246d4-8c2a-4150-b656-c15948bf0e77 https://echa.europa.eu/documents/10162/b8ebce3f-ac89-4efa-b257-e62158a3f961
Lead sulfochromate yellow (C.I. Pigment Yellow 34) - 215-693-7 1344-37-2 Carcinogenic (Article 57a)#Toxic for reproduction (Article 57c) 13/01/2010 https://echa.europa.eu/documents/10162/7d4b0549-413a-4642-ac69-069566c2f624 https://echa.europa.eu/documents/10162/cbb77a48-22b8-4888-b485-8e85731648d2 https://echa.europa.eu/documents/10162/cd44c55f-3473-4c73-a356-ce732b2f3d87 https://echa.europa.eu/documents/10162/db6bd587-864a-4422-a73d-415469cc5187
Lead chromate molybdate sulphate red (C.I. Pigment Red 104) - 235-759-9 12656-85-8 Carcinogenic (Article 57a)#Toxic for reproduction (Article 57c) 13/01/2010 https://echa.europa.eu/documents/10162/9a10159e-0846-488b-8fdb-5162e2bf97f4 https://echa.europa.eu/documents/10162/efa8a662-a744-45f7-a507-14a3dcfc3d15 https://echa.europa.eu/documents/10162/624c2151-d7f2-47d7-ab26-7f4996e81e36 https://echa.europa.eu/documents/10162/84492337-5f4b-476c-921e-afd73181cf6c
Lead chromate
231-846-0 7758-97-6 Carcinogenic (Article 57a)#Toxic for reproduction (Article 57c) 13/01/2010 https://echa.europa.eu/documents/10162/1f928dd4-69c2-494d-8d94-08699be302e5 https://echa.europa.eu/documents/10162/df3d989f-4229-497e-942c-44763337dcf2 https://echa.europa.eu/documents/10162/25e3a7a4-41a4-4f72-8d0f-2ab06a6bf51a

Diisobutyl phthalate
201-553-2 84-69-5 Toxic for reproduction (Article 57c)#Endocrine disrupting properties (Article 57(f) - human health) 13/01/2010 https://echa.europa.eu/documents/10162/8f861ec5-40ca-43d6-be8a-7bc22b96f84f#https://echa.europa.eu/documents/10162/a956b752-1a1b-1316-6ed7-a01d09cd52cd#https://echa.europa.eu/documents/10162/22021d20-ffe6-5b92-8961-4420d5788c06 https://echa.europa.eu/documents/10162/5f086082-c721-442d-8b7b-a6eb49ffb3ab https://echa.europa.eu/documents/10162/96caf4ad-1095-4929-a1b9-84aeea1aff00#https://echa.europa.eu/documents/10162/872ff9cf-52a5-49f4-1e0a-da6ce3e9e074 https://echa.europa.eu/documents/10162/6a39c904-61a6-46e8-a93e-c03083c92d80
Anthracene oil, anthracene-low - 292-604-8 90640-82-7 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#PBT (Article 57d)#vPvB (Article 57e) 13/01/2010 https://echa.europa.eu/documents/10162/709cf01f-1445-4606-a0f2-1940a468dab6 https://echa.europa.eu/documents/10162/ce2619c5-654b-4934-a835-a3e2b00d4e13 https://echa.europa.eu/documents/10162/3e5e6a56-dd4f-4951-b26e-985b7f692624 https://echa.europa.eu/documents/10162/c30d5553-5eec-4a50-b3c9-888d402ccdf0 Does not meet the criteria for identification as a carcinogen if it contains < 0.005 % (w/w) benzo[a]pyrene (EINECS No 200-028-5) and < 0.1 % w/w benzene (EINECS No 200-753-7). Does not meet the criteria for identification as a mutagen if it contains < 0.1 % w/w benzene (EINECS No 200-753-7).
Anthracene oil, anthracene paste, distn. lights - 295-278-5 91995-17-4 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#PBT (Article 57d)#vPvB (Article 57e) 13/01/2010 https://echa.europa.eu/documents/10162/960a181f-7094-4be7-b02f-c49513a0442e https://echa.europa.eu/documents/10162/2a5afd0a-9ce1-4b37-acc9-942143c01c7a https://echa.europa.eu/documents/10162/f0ff9790-013c-49b3-ae93-ac11d2177bf9 https://echa.europa.eu/documents/10162/595f0cbb-fedb-4bfe-986c-e7c9d2951364 Does not meet the criteria for identification as a carcinogen if it contains < 0.005 % (w/w) benzo[a]pyrene (EINECS No 200-028-5) and < 0.1 % w/w benzene (EINECS No 200-753-7). Does not meet the criteria for identification as a mutagen if it contains < 0.1 % w/w benzene (EINECS No 200-753-7).
Anthracene oil, anthracene paste, anthracene fraction - 295-275-9 91995-15-2 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#PBT (Article 57d)#vPvB (Article 57e) 13/01/2010 https://echa.europa.eu/documents/10162/b5013ad5-8980-478b-aa32-4859860f9aef https://echa.europa.eu/documents/10162/4efcaa35-8b9f-4b19-9f81-9f1fb98533b2 https://echa.europa.eu/documents/10162/8de3cd61-aae1-4864-b694-8928dcdea7fd https://echa.europa.eu/documents/10162/d6bbb10d-461d-4181-86a0-fab36ddf1ea8 Does not meet the criteria for identification as a carcinogen if it contains < 0.005 % (w/w) benzo[a]pyrene (EINECS No 200-028-5) and < 0.1 % w/w benzene (EINECS No 200-753-7). Does not meet the criteria for identification as a mutagen if it contains < 0.1 % w/w benzene (EINECS No 200-753-7).
Anthracene oil, anthracene paste - 292-603-2 90640-81-6 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#PBT (Article 57d)#vPvB (Article 57e) 13/01/2010 https://echa.europa.eu/documents/10162/df5aecc8-d928-4a70-9bf0-90ca5953bc44 https://echa.europa.eu/documents/10162/ad049eea-4aeb-4741-9574-ae6c4bd02b66 https://echa.europa.eu/documents/10162/1995aafa-663a-43a0-ae2a-285c842d7f53 https://echa.europa.eu/documents/10162/056aa1f3-4265-4c3a-8fad-ceb73c40acc8 Does not meet the criteria for identification as a carcinogen if it contains < 0.005 % (w/w) benzo[a]pyrene (EINECS No 200-028-5) and < 0.1 % w/w benzene (EINECS No 200-753-7). Does not meet the criteria for identification as a mutagen if it contains < 0.1 % w/w benzene (EINECS No 200-753-7).
Anthracene oil - 292-602-7 90640-80-5 Carcinogenic (Article 57a)#PBT (Article 57d)#vPvB (Article 57e) 13/01/2010 https://echa.europa.eu/documents/10162/f7cfbd7b-2a5a-49aa-9d16-61689ad3a8e3 https://echa.europa.eu/documents/10162/91cfe38e-ed0d-4c28-b970-bded2289de26 https://echa.europa.eu/documents/10162/ef47ccc5-0786-4bf5-b16c-2f13c6c49385 https://echa.europa.eu/documents/10162/eebd5cc3-810e-4150-b6a4-8be5017f631a Does not meet the criteria for identification as a carcinogen if it contains < 0.005 % (w/w) benzo[a]pyrene (EINECS No 200-028-5)
2,4-dinitrotoluene
204-450-0 121-14-2 Carcinogenic (Article 57a) 13/01/2010 https://echa.europa.eu/documents/10162/7700e235-3ba5-44d4-9ab9-5ace916ca7b3 https://echa.europa.eu/documents/10162/a8b8d40f-1cea-4daf-9f49-af3a2b2d50d9 https://echa.europa.eu/documents/10162/b5db559d-a89d-4fc4-a273-dba250fb4201 https://echa.europa.eu/documents/10162/5e8d799f-0aba-4048-9e9f-7f9752930c04
Triethyl arsenate - 427-700-2 15606-95-8 Carcinogenic (Article 57a) 28/10/2008 https://echa.europa.eu/documents/10162/6d48ec99-f364-44de-92a5-62d505ea3724 https://echa.europa.eu/documents/10162/e7756763-29b1-4135-8aa6-2b20d8e672a1 https://echa.europa.eu/documents/10162/d3a393bf-e221-4fa1-8d81-082c2ac3cf8f

Sodium dichromate
234-190-3 10588-01-9, 7789-12-0 Carcinogenic (Article 57a)#Mutagenic (Article 57b)#Toxic for reproduction (Article 57c) 28/10/2008 https://echa.europa.eu/documents/10162/0594aba7-e06e-45bd-807d-3eb9bd74024c https://echa.europa.eu/documents/10162/03566bd3-3a60-40b1-8a7d-86ea5737a0f6 https://echa.europa.eu/documents/10162/52c64496-821b-4a74-bc1a-d9fc2040b651 https://echa.europa.eu/documents/10162/8e7b326a-1fe8-4d93-b9f1-c2d941ecfa0f
Lead hydrogen arsenate
232-064-2 7784-40-9 Carcinogenic (Article 57a)#Toxic for reproduction (Article 57c) 28/10/2008 https://echa.europa.eu/documents/10162/ebdb28e4-ea63-4f11-8b2e-c299ad5ebd07 https://echa.europa.eu/documents/10162/f1ac3df6-c52a-4870-847b-1d6a74e1b034 https://echa.europa.eu/documents/10162/ee0a9b5c-6f5e-43d7-8ef5-76b068bb4732 https://echa.europa.eu/documents/10162/0c38479c-8961-4b41-854e-4dbf1a24db7f
Hexabromocyclododecane (HBCDD) and all major diastereoisomers identified - - PBT (Article 57d) 28/10/2008 https://echa.europa.eu/documents/10162/471aceac-4e5e-4c53-a4b2-23159a290893 https://echa.europa.eu/documents/10162/df4ad28a-899d-4e76-8529-eda8bc6591ae#https://echa.europa.eu/documents/10162/938b85d2-d87c-480a-b697-bad2e5eced3d#https://echa.europa.eu/documents/10162/0412300e-9170-4eb7-87c4-9bd3bad4ca42#https://echa.europa.eu/documents/10162/7b768673-ea38-4822-9712-45b7dca0c2d8#https://echa.europa.eu/documents/10162/63d654f6-5400-449d-81bb-1aa6518d7ca3 https://echa.europa.eu/documents/10162/1fc837ef-f922-476e-8e00-825ab60213c0 https://echa.europa.eu/documents/10162/278fc167-b889-4193-9b62-9008cd51a493
1,2,5,6,9,10-hexabromocyclododecane
221-695-9 3194-55-6 PBT (Article 57d) 28/10/2008 https://echa.europa.eu/documents/10162/471aceac-4e5e-4c53-a4b2-23159a290893 https://echa.europa.eu/documents/10162/df4ad28a-899d-4e76-8529-eda8bc6591ae#https://echa.europa.eu/documents/10162/938b85d2-d87c-480a-b697-bad2e5eced3d#https://echa.europa.eu/documents/10162/0412300e-9170-4eb7-87c4-9bd3bad4ca42#https://echa.europa.eu/documents/10162/7b768673-ea38-4822-9712-45b7dca0c2d8#https://echa.europa.eu/documents/10162/63d654f6-5400-449d-81bb-1aa6518d7ca3 https://echa.europa.eu/documents/10162/1fc837ef-f922-476e-8e00-825ab60213c0 https://echa.europa.eu/documents/10162/278fc167-b889-4193-9b62-9008cd51a493
Hexabromocyclododecane
247-148-4 25637-99-4 PBT (Article 57d) 28/10/2008 https://echa.europa.eu/documents/10162/471aceac-4e5e-4c53-a4b2-23159a290893 https://echa.europa.eu/documents/10162/df4ad28a-899d-4e76-8529-eda8bc6591ae#https://echa.europa.eu/documents/10162/938b85d2-d87c-480a-b697-bad2e5eced3d#https://echa.europa.eu/documents/10162/0412300e-9170-4eb7-87c4-9bd3bad4ca42#https://echa.europa.eu/documents/10162/7b768673-ea38-4822-9712-45b7dca0c2d8#https://echa.europa.eu/documents/10162/63d654f6-5400-449d-81bb-1aa6518d7ca3 https://echa.europa.eu/documents/10162/1fc837ef-f922-476e-8e00-825ab60213c0 https://echa.europa.eu/documents/10162/278fc167-b889-4193-9b62-9008cd51a493
alpha-hexabromocyclododecane
- 134237-50-6 PBT (Article 57d) 28/10/2008 https://echa.europa.eu/documents/10162/471aceac-4e5e-4c53-a4b2-23159a290893 https://echa.europa.eu/documents/10162/df4ad28a-899d-4e76-8529-eda8bc6591ae#https://echa.europa.eu/documents/10162/938b85d2-d87c-480a-b697-bad2e5eced3d#https://echa.europa.eu/documents/10162/0412300e-9170-4eb7-87c4-9bd3bad4ca42#https://echa.europa.eu/documents/10162/7b768673-ea38-4822-9712-45b7dca0c2d8#https://echa.europa.eu/documents/10162/63d654f6-5400-449d-81bb-1aa6518d7ca3 https://echa.europa.eu/documents/10162/1fc837ef-f922-476e-8e00-825ab60213c0 https://echa.europa.eu/documents/10162/278fc167-b889-4193-9b62-9008cd51a493
beta-hexabromocyclododecane
- 134237-51-7 PBT (Article 57d) 28/10/2008 https://echa.europa.eu/documents/10162/471aceac-4e5e-4c53-a4b2-23159a290893 https://echa.europa.eu/documents/10162/df4ad28a-899d-4e76-8529-eda8bc6591ae#https://echa.europa.eu/documents/10162/938b85d2-d87c-480a-b697-bad2e5eced3d#https://echa.europa.eu/documents/10162/0412300e-9170-4eb7-87c4-9bd3bad4ca42#https://echa.europa.eu/documents/10162/7b768673-ea38-4822-9712-45b7dca0c2d8#https://echa.europa.eu/documents/10162/63d654f6-5400-449d-81bb-1aa6518d7ca3 https://echa.europa.eu/documents/10162/1fc837ef-f922-476e-8e00-825ab60213c0 https://echa.europa.eu/documents/10162/278fc167-b889-4193-9b62-9008cd51a493
gamma-hexabromocyclododecane
- 134237-52-8 PBT (Article 57d) 28/10/2008 https://echa.europa.eu/documents/10162/471aceac-4e5e-4c53-a4b2-23159a290893 https://echa.europa.eu/documents/10162/df4ad28a-899d-4e76-8529-eda8bc6591ae#https://echa.europa.eu/documents/10162/938b85d2-d87c-480a-b697-bad2e5eced3d#https://echa.europa.eu/documents/10162/0412300e-9170-4eb7-87c4-9bd3bad4ca42#https://echa.europa.eu/documents/10162/7b768673-ea38-4822-9712-45b7dca0c2d8#https://echa.europa.eu/documents/10162/63d654f6-5400-449d-81bb-1aa6518d7ca3 https://echa.europa.eu/documents/10162/1fc837ef-f922-476e-8e00-825ab60213c0 https://echa.europa.eu/documents/10162/278fc167-b889-4193-9b62-9008cd51a493
Dibutyl phthalate (DBP)
201-557-4 84-74-2 Toxic for reproduction (Article 57c)#Endocrine disrupting properties (Article 57(f) - human health) 28/10/2008 https://echa.europa.eu/documents/10162/d33fd29e-5170-440f-8c16-10ecd87cf472#https://echa.europa.eu/documents/10162/2f10864f-e748-0e86-9bc4-2b3964fbdace#https://echa.europa.eu/documents/10162/326a8103-bc47-fb36-0871-22b46ec9d66f https://echa.europa.eu/documents/10162/431cf3aa-7e2f-43d5-ad4c-6b80ad7fbc91 https://echa.europa.eu/documents/10162/f36205a8-df0a-4e94-8763-2a6a02f0228c#https://echa.europa.eu/documents/10162/6b0b59e9-8ba8-03de-e8e9-735414f0611d https://echa.europa.eu/documents/10162/a9ce452c-0c10-48f6-aa7f-48fec798197f
Diarsenic trioxide
215-481-4 1327-53-3 Carcinogenic (Article 57a) 28/10/2008 https://echa.europa.eu/documents/10162/d502da18-827f-408d-aa24-9fe0c7e6ed1b https://echa.europa.eu/documents/10162/03f099fc-0057-49d9-a816-24c44d69b5c1 https://echa.europa.eu/documents/10162/8730b910-c1d4-4b87-b3e3-a94ce47fbc9b https://echa.europa.eu/documents/10162/ce0d5fc7-ece9-4f28-9bfa-7d22e487be5b
Diarsenic pentaoxide
215-116-9 1303-28-2 Carcinogenic (Article 57a) 28/10/2008 https://echa.europa.eu/documents/10162/7b11c857-a72d-4a8b-9efb-68d99ead7902 https://echa.europa.eu/documents/10162/76037d34-1e8c-405e-b594-8fe837e6095e https://echa.europa.eu/documents/10162/91206b72-787f-4a2d-aa80-9d6f1f22fc55 https://echa.europa.eu/documents/10162/181f30b7-6776-4c7d-be36-8f2cc3300749
Cobalt dichloride
231-589-4 7646-79-9 Carcinogenic (Article 57a)#Toxic for reproduction (Article 57c) 28/10/2008 https://echa.europa.eu/documents/10162/5633d67c-a61b-4bab-b6c5-c4a61cc99e00#https://echa.europa.eu/documents/10162/39173d0d-3258-4f23-ab18-a586bcb39567 https://echa.europa.eu/documents/10162/383cf518-9e20-495c-bbcf-8875b9373714 https://echa.europa.eu/documents/10162/7d541979-6f03-421b-91bb-039bfb326de1#https://echa.europa.eu/documents/10162/fdbfa509-c244-4537-85eb-07994f393f23 https://echa.europa.eu/documents/10162/27e3dd9f-3104-4137-a9c9-930124ef07f8
Bis(tributyltin) oxide (TBTO)
200-268-0 56-35-9 PBT (Article 57d) 28/10/2008 https://echa.europa.eu/documents/10162/1b18d017-1056-4c92-aeeb-f190ad674174 https://echa.europa.eu/documents/10162/e7faa0f6-cb40-4930-8931-537d261e43ff https://echa.europa.eu/documents/10162/52f3fc94-c78f-436f-98ca-e0f845f37a9a https://echa.europa.eu/documents/10162/79766485-e0a7-483c-9f7a-33e2df96819e
Bis (2-ethylhexyl)phthalate (DEHP)
204-211-0 117-81-7 Toxic for reproduction (Article 57c)#Endocrine disrupting properties (Article 57(f) - environment)#Endocrine disrupting properties (Article 57(f) - human health) 28/10/2008 https://echa.europa.eu/documents/10162/c2ecc989-445d-40b9-a054-28671849b092#https://echa.europa.eu/documents/10162/30b654ce-1de3-487a-8696-e05617c3173b#https://echa.europa.eu/documents/10162/3b0d2893-b8db-86b9-6db0-6e06dc9aa10e#https://echa.europa.eu/documents/10162/88c20879-606b-03a6-11e4-9edb90e7e615 https://echa.europa.eu/documents/10162/331e209a-627f-4533-8690-fd33b74f305d https://echa.europa.eu/documents/10162/9e33725c-05fc-41af-b06d-bb969c91b0ab#https://echa.europa.eu/documents/10162/fa429d23-21e7-4764-b223-6c8c98f8a01c#https://echa.europa.eu/documents/10162/3f5d91bc-0a63-04f8-8f62-ccc9c8265e7d https://echa.europa.eu/documents/10162/074bcc74-7e38-4244-8ab1-ed7d67cf18eb
Benzyl butyl phthalate (BBP)
201-622-7 85-68-7 Toxic for reproduction (Article 57c)#Endocrine disrupting properties (Article 57(f) - human health) 28/10/2008 https://echa.europa.eu/documents/10162/7cad31ee-4818-4166-9212-b39ca33240bb#https://echa.europa.eu/documents/10162/dd4a532e-e277-5b52-9ba2-a94be60b7f17#https://echa.europa.eu/documents/10162/cfb492f3-424f-712c-130b-01c6e2d5074a https://echa.europa.eu/documents/10162/20b09a46-f289-4e35-92d2-9cd039e71ba5 https://echa.europa.eu/documents/10162/b4024445-00ce-4849-9ab0-69aed88c51f2#https://echa.europa.eu/documents/10162/076491e2-fd0e-50be-61b4-908c663d0245 https://echa.europa.eu/documents/10162/798dad0a-7821-4599-b87a-18235b85c448
Anthracene
204-371-1 120-12-7 PBT (Article 57d) 28/10/2008 https://echa.europa.eu/documents/10162/143cd93d-ee58-40c1-b0f1-3713cbb11535 https://echa.europa.eu/documents/10162/c5f3267f-609d-4ccb-8645-5b7e02d3946c https://echa.europa.eu/documents/10162/f7c1321a-6709-40d6-b683-1fb870fb0ac4 https://echa.europa.eu/documents/10162/87622091-3722-4de3-b2e9-6a4882d3df5e
Alkanes, C10-13, chloro (Short Chain Chlorinated Paraffins)
287-476-5 85535-84-8 PBT (Article 57d)#vPvB (Article 57e) 28/10/2008 https://echa.europa.eu/documents/10162/e9713dc8-1855-4dab-9635-72ca8be244ae https://echa.europa.eu/documents/10162/c0c51b06-7e2e-4934-b46f-0ba82015047c https://echa.europa.eu/documents/10162/2edcfedb-ec53-4754-8598-e787a8ff7a58 https://echa.europa.eu/documents/10162/f8ae5f41-42d3-4d13-83c9-3524a5609988
5-tert-butyl-2,4,6-trinitro-m-xylene (Musk xylene)
201-329-4 81-15-2 vPvB (Article 57e) 28/10/2008 https://echa.europa.eu/documents/10162/e3747ed6-99b4-43d1-92ae-9c837ded241d https://echa.europa.eu/documents/10162/e8716cf9-db7f-4073-88fa-18dd4480c61f https://echa.europa.eu/documents/10162/909dd42e-2554-4f59-911a-729a2da1d529 https://echa.europa.eu/documents/10162/8e23992a-a835-44a8-96c4-049c6b2e7b7a
4,4'- Diaminodiphenylmethane (MDA)
202-974-4 101-77-9 Carcinogenic (Article 57a) 28/10/2008 https://echa.europa.eu/documents/10162/68f50f10-f55f-40be-9d1b-4fbbfdec7f96 https://echa.europa.eu/documents/10162/1c864bd5-399d-49a2-880b-a8ad54d458b5 https://echa.europa.eu/documents/10162/d36424e7-b12d-4dd8-832e-6d7e3e283fc3 https://echa.europa.eu/documents/10162/9742c151-381b-4078-9d97-42f0d41a3110